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Resumo
O microbiota humano (a soma de todos os microrganismos que colonizam o corpo humano) e´
composto aproximadamente por 1e+14 ce´lulas bacterianas, que abrangem va´rios taxa, e colonizam
principalmente a pele, mucosas, tecido conjuntivo, e o tracto gastrointestinal, nomeadamente o co´lon.
O somato´rio de todos os genomas microbianos que lhe dizem respeito e´ frequentemente denominado
microbioma.
O conjunto de genes que codificam viruleˆncia (eventualmente conferindo patogenicidade a`
bacte´ria) sa˜o frequentemente codificados em elementos gene´ticos mo´veis. Deste modo, muitos factores
de viruleˆncia (VF) bacteriana conseguem ser facilmente disseminados em populac¸o˜es bacterianas por
transfereˆncia horizontal de genes (movimento de material gene´tico entre ce´lulas), convertendo bacte´rias
mutualistas ou comensais em potenciais patogenes.
Analogamente, a colecc¸a˜o de genes cujos determinantes (produtos ge´nicos) conferem resisteˆncia a
antibio´ticos (AR), existentes tanto em bacte´rias patoge´nicas como na˜o-patoge´nicas, tambe´m se apresenta
repetidamente codificada em elementos gene´ticos mo´veis, os quais sob pressa˜o selectiva, se conseguem
disseminar por entre comunidades bacterianas atrave´s do processo de transfereˆncia horizontal de genes,
atravessando por vezes as barreiras taxono´micas de espe´cie e ge´nero. Esta caracterı´stica permite que
a comunidade sobreviva, e persista como um todo, comportando-se como um reservato´rio de genes
conferentes de resisteˆncia.
Microbiomas ambientais, como os que se encontram presentes no solo, sa˜o descritos como
reservato´rios abundantes de genes de resisteˆncia a antibio´ticos. Estes codificam para determinantes de
resisteˆncia a todas as classes de antibio´ticos descritas ate´ hoje.
Apesar da antibioticoterapia ser direcionada a bacte´rias patoge´nicas, esta tambe´m afeta muitas
espe´cies bacterianas na˜o-patoge´nicas que fazem parte do microbiota dos indivı´duos sujeitos a este tipo
de terapia medicamentosa. Efeito que tambe´m se verifica em bacte´rias ambientais que se encontrem
expostas a este tipo de pressa˜o selectiva consequente de ma´s pra´ticas agra´rias e da pecua´ria, ou
simplesmente poluic¸a˜o antropolo´gica.
Por conseguinte, o microbioma humano dete´m genes de resisteˆncia passiveis de transmissa˜o a
estirpes patoge´nicas, tornando-o num reperto´rio de determinantes de resisteˆncia a antibio´ticos altamente
diversificado.
O estilo de vida virulento, caracterı´stico de bacte´rias patoge´nicas, tem sido consecutivamente
associado a feno´tipos de resisteˆncia a antibio´ticos. No entanto, esta associac¸a˜o nem sempre tem sido
direta e previsı´vel. Por um lado, o crescente uso de antibio´ticos tem vindo a seleccionar bacte´rias
detentoras de feno´tipos resistentes, sejam elas patoge´nicas ou na˜o, criando reservato´rios gene´ticos de
resisteˆncia em diversos microbiomas. Porventura na˜o e´ claro se a diversidade de genes conferentes
de viruleˆncia se correlaciona com a diversidade dos que conferem resisteˆncia a antibio´ticos. Em
contrapartida, existem inu´meros relatos bibliogra´ficos de estirpes altamente virulentas e multi-resistentes
(resistentes a mais do que uma classe de antibio´tico) que teˆm vindo a disseminar-se por todo o globo.
Tendo em conta que atualmente existe uma grande disponibilidade de antibio´ticos, e em alguns
casos, administrac¸a˜o na˜o supervisionada, podemos concluir que os microbiotas humanos, bem como
os seus respectivos microbiomas, esta˜o sujeitos a diferentes graus de presso˜es seletivas impostas pelos
referidos compostos.
Neste contexto, podemos inferir que para alguns patogenes, em ordem a sobreviver e colonizar
o hospedeiro, codificar apenas para viruleˆncia pode na˜o ser suficiente, se se encontrarem na presenc¸a
de antibio´ticos. Por outras palavras, sob o efeito de presso˜es seletivas impostas pela administrac¸a˜o
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de antibio´ticos, a selec¸a˜o de elementos gene´ticos mo´veis que codifiquem para resisteˆncia aos referidos
compostos juntamente com caracterı´sticas genotı´picas que confiram viruleˆncia ira´ ocorrer, tendo
como consequeˆncia a sua disseminac¸a˜o dentro de comunidades bacterianas pertencentes ao microbiota
humano.
Tanto quanto sabemos, na˜o existem registos bibliogra´ficos sobre a dinaˆmica evolutiva que dita
a epidemiologia de genes conferentes de resisteˆncia a antibio´ticos, e os que conferem viruleˆncia,
colectivamente. Assim sendo, a presente dissertac¸a˜o pergunta se sob o efeito de presso˜es seletivas
exercidas por antibio´ticos, os determinantes de resisteˆncia e de viruleˆncia se encontram co-representados
tanto em diversos microbiomas ambientais, como em microbiomas provenientes do trato gastrointestinal
humano.
Deste modo, foram escolhidos metagenomas a fim de abordar esta tema´tica por va´rias razo˜es.
A mais preeminente prende-se com o facto das bacte´rias serem organismos sociais, vivendo em
comunidades. Um metagenoma corresponde a` pano´plia de material gene´tico isolado de uma
comunidade, e posteriormente sequenciado, pelo que caracteriza o reperto´rio completo de genes
envolvidos em processos metabo´licos, fisiolo´gicos e ecolo´gicos, como por exemplo, na adaptac¸a˜o ao
ambiente pelas comunidades microbianas presentes na respectiva amostra sequenciada.
Subsequentemente, a prospecc¸a˜o de genes em metagenomas surge como uma metodologia
fidedigna no que toca ao estudo das presso˜es seletivas a que uma dada populac¸a˜o bacteriana foi sujeita,
assim como ao estudo da co-selec¸a˜o de caracterı´sticas gene´ticas do microbiota amostrado como um todo.
No presente trabalho utilizamos 64 metagenomas ambientais, referentes a 12 biomas diversos, bem
como 110 metagenomas do trato gastrointestinal humano, origina´rios de indivı´duos pertencentes a va´rias
comunidades dos Estados Unidos da Ame´rica, Venezuela, e Malawi, caracterizando va´rias faixas eta´rias,
diferentes culturas, ha´bitos alimentares, bem como diferentes graus de acesso a saneamento ba´sico, a
cuidados me´dicos e antibio´ticos. Todos os metagenomas encontram-se publicamente disponı´veis para
download no servidor MG-RAST, tendo sido descarregados em ficheiros individuais em formato FASTA,
nos dias 3 de Abril de 2015 (metagenomas do trato gastrointestinal humano) e 17 de Novembro de 2015
(metagenomas ambientais). Cada ficheiro compreende sequeˆncias proteicas previamente agrupadas a
90% de homologia pela pipeline de formatac¸a˜o de ficheiros do servidor MG-RAST, contendo assim
sequeˆncias traduzidas na˜o redundantes, e representando deste modo a diversidade proteica de cada
metagenoma.
O programa BLASTP foi utilizado a fim de inferir homologia de sequeˆncias proteicas envolvidas
no feno´meno de resisteˆncia a antibio´ticos, bem como de viruleˆncia, de entre os metagenomas escolhidos,
fazendo uso de duas bases-de-dados pu´blicas: Resfams AR Proteins database (base-de-dados de
proteı´nas bacterianas conferentes de resisteˆncia a antibio´ticos), e VFDB (base-de-dados de proteı´nas
bacterianas envolvidas em viruleˆncia). Este programa permite inferir homologia entre sequeˆncias
comparadas por via de um algoritmo de alinhamento de sequeˆncias derivado do algoritmo original de
Smith-Waterman.
De entre os va´rios crite´rios de seriac¸a˜o aplica´veis foi escolhido um limiar de E-value = 1e-15,
com um filtro posterior que apenas considera o melhor alinhamento para cada sequeˆncia proteica, e
que satisfac¸a os requisitos mı´nimos de 60% de homologia sob 75% de alinhamento entre sequeˆncias
comparadas. Ulteriormente ainda se removeram os alinhamentos resultantes de sequeˆncias proteicas que
tanto eram homologas de determinantes de resisteˆncia a antibio´ticos como de factores de viruleˆncia, de
modo a eliminar um vie´s na ana´lise estatı´stica consecutivamente implementada.
Seguidamente, de modo a aferir o tipo de relac¸a˜o entre os caracteres gene´ticos em causa, as
contagens das diferentes sequeˆncias proteicas homologas de determinantes de resisteˆncia a antibio´ticos
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(ARd) foram correlacionadas numa primeira fase com o nu´mero de sequeˆncias proteicas presentes em
cada metagenoma, previamente agrupadas a 90% (tamanho do metagenoma), procedendo de igual forma
para as contagens de diversidade de sequeˆncias proteicas homologas de factores de viruleˆncia (VFd),
para ambos os grupos de metagenomas considerados. Posteriormente as contagens ARd e VFd foram
correlacionadas entre si, apo´s a estandardizac¸a˜o das mesmas. Em ordem a medir o grau de associac¸a˜o
entre as correlac¸o˜es previamente descritas recorreu-se a medidas estatı´sticas como o coeficiente de
correlac¸a˜o e o rho de Spearman, bem como o seu P-value. Foram tambe´m geradas todas as possı´veis
associac¸o˜es entre as contagens de ARd e VFd para subfamı´lias proteicas funcionais caracterizadas nas
bases-de-dados mencionadas, efetuando uma correc¸a˜o aos P-values resultantes do rho de Spearman pelo
procedimento de Benjamini-Hochberg.
Em ordem a testar a dissemelhanc¸a entre me´dias provenientes dos ra´cios estandardizados
de ARd/VFd em func¸a˜o da idade dos indivı´duos pertencentes ao grupo de metagenomas do trato
gastrointestinal humano, foram aplicados Welch Two Sample t-tests por pares, de acordo com os
respectivos paı´ses de origem.
Os nossos resultados mostram que os determinantes de resisteˆncia a antibio´ticos, bem como os
factores de viruleˆncia, se encontram amplamente disseminados tanto em microbiomas ambientais, como
em microbiomas do trato gastrointestinal humano pertencentes aos 110 indivı´duos sauda´veis origina´rios
de paı´ses diferentes.
Em segundo lugar, tambe´m sugerem que, apesar das comunidades bacterianas ambientais
possuı´rem maior variac¸a˜o de ARd e VFd tendo em conta o tamanho dos metagenomas, as comunidades
que habitam o trato gastrointestinal humano deteˆm uma dependeˆncia linear muito forte no que toca a`
distribuic¸a˜o de ARd de acordo com o tamanho dos metagenomas, e uma relac¸a˜o linear forte entre VFd e
o tamanho dos mesmos.
Adicionalmente constatamos que as contagens estandardizadas de ARd e VFd apresentam uma
correlac¸a˜o muito forte entre si nos metagenomas de origem ambiental, sendo que estas contagens
tambe´m se mostraram fortemente correlacionadas no grupo de metagenomas provenientes do trato
gastrointestinal humano. Entre os metagenomas do grupo anterior, os referentes aos indivı´duos
origina´rios dos Estados Unidos da Ame´rica, apresentam uma ampla diversidade de associac¸o˜es, ao passo
que as amostras provenientes de indivı´duos Venezuelanos na˜o possuem uma associac¸a˜o estatisticamente
relevante. No entanto, os metagenomas pertencentes a indivı´duos Malauianos retratam a correlac¸a˜o
e associac¸a˜o linear mais forte de entre os treˆs paı´ses amostrados, possuindo tambe´m duas vezes mais
contagens de ARd por VFd que os outros dois paı´ses.
Referindo-nos ainda ao mesmo conjunto de metagenomas, conseguimos verificar que as contagens
estandardizadas de ARd e VFd aparentam decrescer com o aumento da idade dos indivı´duos, enquanto
que os ra´cios ARd/VFd afiguram-se relativamente esta´veis, evidenciando um incremento comum durante
o primeiro ano de vida.
Relativamente a todas as associac¸o˜es geradas entre subfamı´lias de proteı´nas que codificam para
AR e as que codificam VFs, aquelas que se relacionam com o envelope celular bacteriano apresentaram
as melhores correlac¸o˜es e estatı´sticas correspondentes.
E´ de salientar que os resultados descritos neste trabalho apenas fornecem evideˆncia para
a co-representac¸a˜o de determinantes de AR e VF entre os metagenomas ambientais e do trato
gastrointestinal humano que foram amostrados. Visto que a inclusa˜o ou proximidade de determinantes
AR e VF nos mesmos elementos gene´ticos mo´veis na˜o se prende com os objectivos da presente
dissertac¸a˜o, os nossos resultados na˜o podem confirmar que a mobilizac¸a˜o dos demais determinantes
esteja a ocorrer conjuntamente. De qualquer modo, a natureza co-representativa dos nossos resultados
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reforc¸a a noc¸a˜o, bem como a hipo´tese de co-selec¸a˜o dos referidos determinantes.
Palavras-Chave: Resisteˆncia a antibio´ticos; viruleˆncia; microbiomas humanos; microbiomas
ambientais; metageno´mica
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Abstract
Genes contributing to the pathogenicity of a particular bacterial species are often grouped in
pathogenicity islands, and encoded on mobile genetic elements such as plasmids or phages, as happens
with some genes coding for resistance to antibiotics. Pathogenic bacteria have gradually become
resistant to antibiotics as a result of intense selective pressure they are subjected to. Here we provide
evidence that further reinforces the hypothesis on which, under antibiotics selective pressure, resistance
and virulence traits are co-selected amongst bacterial communities naturally occurring in the human gut
microbiome. Through means of metagenome mining, we have studied 64 environmental metagenomes
from 12 diverse biomes, as well as 110 human gut metagenomes issuing from individuals belonging
to different human populations across the world, having contrastive cultural, dietary and sanitary
lifestyles, along with different medical access to antibiotics. Our results demonstrate that there is a great
diversity of antibiotic resistance (AR) and virulence factor (VF) genetic traits amongst metagenomes in
general. In the human gut there are less AR and VF genetic traits than in more versatile environments,
yet the correlations between the latter determinants are still strong, advocating that in the human gut
microbiome, there appears to be co-selection of these traits, remaining well established and long lasting
in the foregoing host’s microbiome. In the USA human gut metagenomes there are a few examples of
AR determinants per VF accumulation, suggesting a possible consequence of antibiotic consumption
abuse. In Malawi, a very poor African country, where there is a high prevalence of unattended
antibiotic consumption, the correlation between AR determinants and VFs is very strong, as opposed
to the scenario portrayed by the metagenomes pertaining to Amerindians (native populations of the
Venezuelan Amazon) where there is neither reports of pharmaceutical-grade antibiotics consumption
nor correlation at all, thus allowing us to link this effect to antibiotic exposure. Furthermore, the best
correlations gathered between AR and VF protein sub-families amidst both metagenomic cohorts relate
to the bacterial cell envelope, namely multidrug efflux pump components (AR determinants), along with
secretion systems, adhesion proteins and iron-acquisition systems (VFs), most of which are known to be
encoded within mobile genetic elements.
Keywords: Antibiotic resistance; virulence; human gut microbiome; environmental microbiomes;
metagenomics
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1. Introduction
1.1 Brief conceptualization on the human gut Microbiota
Microbial communities constitute the bedrock of life on Earth, and have seemingly been crucial
for the very evolution of life, as we perceive it [1]. Fourteen years ago, Carl R. Woese conjured that the
first steps of evolution did not arise from selective pressures imposed on intralineage variations nor on
individual genealogical traces, but rather from imposing these pressures to the community as a whole,
the ecosystem [1]. Quite possibly, these first microbial communities, although primitive in nature, bore
striking resemblances to those of more primeval microbes found nowadays throughout the biosphere.
It is likely that the extent of innovations required by microorganisms to become divergent in terms of
cellular lineages, and populate the vastness of ecosystems present in today’s biosphere, required whole
communities to exchange molecular information. Henceforth, one of many milestones of microbial
evolution lies in community dynamics, as a purported singular unit [1].
Fossil records date the occurrence of one of the first evidences of spatially organized microbial
communities as soon as 3.25 billion years ago [2]. On the other hand, multicellular eukaryotic life
is thought to have emerged around 1.2 billion years ago [3]. The two previous statements provide
us with an insight into the extensive period of time on which both microbial communities and
multicellular life forms interacted, and quite possibly wrought each other’s evolutionary pathway [4].
Indisputable evidence of such associations can be ascertained since diverse multicellular eukaryotes,
namely vertebrates, maintain evolutionary conserved responses to microbial colonization [5,6]. Amongst
the previously stated are humans, whose genome is in due part product of the prime factors that behest
the associations we have developed with our microbial neighbors, suggesting that these associations are
not only due to mere cohabitation, but also due to the exchange of information (e.g.: changes in nutrient
intake) between the host and the microbial communities inhabiting it [5].
The human body has been regarded to be inhabited by more bacteria than the number of
mammalian cells it comprises by tenfold, and it has been further implied that such bacteria enclose
100-fold more unique genes than our very own genome [4,5] (where a genome is the collective sum
of all the genes present within a given organism). The coinage of the term microbiota is commonly
attributed to Joshua Lederberg, who defined it as “the ecological community of commensal, symbiotic,
and pathogenic microorganisms that literally share our body space” [7]. Nevertheless, one can thusly
apply this definition to the microbial communities present in other animals, as well as plants. Several
other definitions of the human microbiota have risen since then, and the same concept can be formally
conveyed as the totality of microorganisms that inhabit the specific ecological niches comprised by the
human body, as a whole. Whereas the collective sum of their respective genomes is commonly named
microbiome [8]. The concept of microbiome is usually applied throughout the literature in a much
broader sense, owing to the fact that a microbiome can be of environmental nature [9]. Nonetheless,
although these terms are sometimes used interchangeably, as if they were synonymous, semantically
speaking, many authors make a clear distinction between the definitions of microbiota and microbiome,
in order to describe either the communities of microorganisms themselves, or the collection of their
genomes, respectively [4,5,8]. For clarification purposes, the present dissertation will acknowledge and
make use of such distinction.
Further drawing on the concept of microbiome, one should also be acquainted with the term
metagenome. A metagenome, similarly to a microbiome, can be defined as the collective sum of
genes directly sequenced from a given environmental sample. Hence, a metagenome can portray the
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phylogenetic and metabolic diversity present within a microbial community, factor which can lead to its
analysis, and further study, somewhat similarly to that of a singular genome. This way of approaching
microbial community analysis, named metagenomics, was first quoted by Jo Handelsman, Jon Clardy,
Robert M. Goodman, Sean F. Brady, and other colleagues, who also coined the term “metagenome” in
1998 [10].
The vast majority of the foregoing prokaryotic cells that compose the human microbiota is
encompassed within our gut (i.e.: the human gastrointestinal tract) [5], particularly the colon where
concentrations approach 1e+11 ~ 1e+12 cells/ml, which in due term pinpoint it as the most densely
populated microbial habitat recorded thus far [11]. Human gut’s microbial community is noteworthy
for its singularity in terms of phylogenetic diversity, given the inner workings of constant selective
pressures exerted indirectly by the host (such as the physical and chemical setting; nutrient intake;
host immune system; fewer biochemical niches than several environments, like the soil) [4] prune this
diversity by members of just two divisions of bacteria – the Bacteroidetes and Firmicutes – and one
member of Archaea, Methanobrevibacter smithii [12]. However, the human gut microbiota preferentially
assorts itself into three well-defined bacterial community configurations (i.e.: clusters), with distinct
metabolic and phylogenetic signatures. These cluster assortments have been coined by Arumugam and
colleagues as enterotypes [13]. Moreover, differences concerning human gut microbiota diversity can
arise from inter-individual and even intra-subject comparisons, the latter being due to surface-dwelling
and lumen-dwelling microbial populations being contrastive and performing different tasks within the
ecosystem (e.g.: stool versus mucosal communities) [12]. As such, these assortments may not exhibit an
explicit arrangement throughout the major subdivisions of the colon and its lumen, but can instead reveal
the presence of specialized microbiological niches [12]. The diversity reported insofar may very well
be a consequence, at a lower phylogenetic level (e.g.: genus, species), of persistent colonization efforts
exerted by the most bountiful representatives within the same biochemical niches [14].
Amongst the autochthonous microbiota’s diversity underlies a complex network of
interrelationships, between the host and the microbiota, and amidst the microbiota itself. The
relationships that make up this intricate system are resultant of a prolonged and complex co-evolutionary
process, as stated above [4]. These interconnections, between the host and its respective microbiota
are suggested to be mutualistic rather than commensal, mainly because the term commensal – as duly
noted by Ba¨ckhed et al. [5] – typically conveys a noncommittal stance when referring to the undeniable
beneficence of most individuals pertaining to this microbial community, to our own gain in terms of
fitness, or to that of other community members [5]. From our point of view, the host, it comes as
preeminent to fathom the beneficial labors our gut microbiota undertakes, which conclusively end up
affecting our fitness as individuals. Although human beings can survive in the absence of gut microbiota
[15], the latter is crucial to the host’s innate digestive processes and nutrient acquisition. The gut
microbiota generates several nutrients derived from substrates that would be otherwise indigestible
by the host’s gastrointestinal tract, namely xyloglucans and short-chain fatty acids [16]. It has also
been summarized by LeBlanc et al. [17], that the gut microbiota’s constituents are able to synthesize
some vitamins, like vitamin K, and most of the B-complex vitamins, such as biotin, cobalamin,
folates, nicotinic acid, panthotenic acid, pyridoxine, riboflavin and thiamine [17]. Focusing on some
other, more conspicuous roles our gut microbiota plays, when it comes to our gain as host, we have:
cardiovascular protection, host fat storage regulation, immunomodulation, inhibition of pathogens,
normal gut motility, protection against injuries inflicted upon epithelial cells, and even stimulation of gut
angiogenic processes [12,18]. From the gut microbiota’s standpoint on this two-way relationship, one
should mention that the microorganisms that encompass it are provided with (almost) constant nutrient
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flow (particularly polysaccharides), protection from prospective competitors, and a specialized anoxic
environment [5].
Emphasizing on the reasoning that has been built up thus far, we have that the human body
(particularly the gut) and its microbiota have underwent millions of years of co-evolutionary processes
[4], while developing a mutualistic partnership where both the microorganisms and the host are
interconnected with one another in several ways, where the first is reliant on the latter on several aspects
[5]. Firstly, the diverse microbial community in the gut is dependent on its host for an ecological
environment in which to survive and is therefore also susceptible to the underlying environmental factors
exposed to the host. Secondly, the microorganisms within the human gut are also proven to be more
adaptable and to change in a faster manner than its host genome, potentially providing it with quick
adaptive advantages [5]. The preceding remark portends that each member in this mutualistic relationship
may find itself under different selective pressures: the microbiota is susceptible to changes when its host
diet is reformed, when environments are briskly altered, or when bestowed upon with chemical agents,
such as antibiotics. On the contrary, the human genome is subject to adaptation only either through
mutational or epigenetic events underwent between generations [19].
However, the communion between host and its microbiota is not always amicable. Despite the
fact that the aforementioned relationships are in its overwhelming majority mutualistic in nature, there
are instances where pathogens arise, disrupting and/or taking advantage of the community dynamics
while usually causing a disease state to the host [4,20]. Still, from an enteric outlook, there seems to
be a distinction between the classical view of pathogenesis where a recent (i.e.: non-preexistent), acute
disease state, is caused by the arrival of an alien pathogen that has infiltrated the intrinsic microbiota,
versus dysbiosis – also referred to as dysbacteriosis. The former designation can be fairly described
as a disruption in the equilibrium that lies between the putative species of beneficial and potentially
opportunistic harmful bacteria [21]. Sometimes this disequilibrium is chronically perpetrated so that
the whole gut microbiota can become harmful to its host, as happens with several maladies such as
irritable bowel syndrome, inflammatory bowel disease, nonalcoholic fatty liver disease and obesity [22].
Yet, the question of whether dysbiosis is a cause or a consequence of some of the mentioned illnesses
remains elusive. Elaborating on this notion of dysbiotic pathogens, one can view them as pertaining to an
assemblage in which the whole microbial community is regarded as “harmful”. In other words, it is not
as beneficial to its host as a “healthy” community would be. In this community, no sole microbial cell
can be witnessed as a pathogen by itself. Instead, the community as a whole composes a circumstantial
hazard that adds up to a disease state. Additionally, this microbial community should be acknowledged
as pathogenic always within the ambiance of other emergent factors, such as host genome, diet, and
risk behaviors [4]. This dissertation will acknowledge the distinctions made heretofore and will refer to
pathogenicity in a “classical” sense, as opposed to dysbiosis, unless stated otherwise.
1.2 Bacterial Pathogens and Virulence Factors
A pathogen is defined as a microbe that can cause damage to its host. And once again, this
definition can encircle pathogens as parasites in a classical sense, as well as opportunistic ones (i.e.:
dysbiosis). The damage sustained by the host, usually manifested as a disease state, may either be
consequent from actions enforced by the pathogen itself or the host’s immune system. Subsequently,
virulence can be deemed as the relative capacity that a pathogen possesses in order to cause damage to a
host, minding that virulence factors (VFs) – also known as virulence determinants – are the components
of a pathogen that enable it to cause damage upon the host [20].
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Pathogenic bacteria have always been a notorious threat to public health and Humankind’s survival,
causing misery and death in its wake throughout recorded history [23]. Perhaps the most blatant example
of such statement was the Black Death pandemic (also known as Black Plague or Bubonic Plague)
that laid waste to Europe in the 14th century, resulting in the death of tens of millions of people [24].
This plague continued to plunder the Continent far into the 18th century, with countless epidemic
resurgences [24]. Several clones of the Yersinia pestis bacterium have been held accountable for said
devastation after DNA analysis of human skeletons dating from the 14th-17th centuries, pertaining to
presumable victims from northern, central, and southern Europe was first made public in 2010 [24].
Nowadays there are still plenty of disease-causing bacteria, which often lead to epidemics that threaten
society, and health-care systems worldwide. One of the most noteworthy bacterial pathogens that has
been resurfacing countless times in epidemic waves, either in developed or developing countries, is
Vibrio cholerae, which causes Cholera, with the remarkable peculiarity of only affecting human beings
[25]. Since 1817, seven documented cholera pandemics have tormented mankind, although the disease
itself has been depicted as early as the 5th century BC [26]. Despite the fact that the state of the
disease can be often classified as moderate or asymptomatic, some of the afflicted patients show profuse
watery diarrhea and vomiting. Severe disease-states display tremendous loss of bodily fluids, quickly
resulting in dehydration, hypovolemic shock (drastic volume decrease of blood plasma, resultant from
acute dehydration), and subsequent death [25]. The predominant symptoms the disease portrays are a
blunt consequence of two major VFs expressed by V. cholerae: the cholera toxin (CTX), and the toxin
co-regulated pilus, the last being indispensable for the pathogen’s further colonization of the intestine
[25].
Outlining the fact that this bacterial pathogen is human-exclusive, the previous statement poses as
a quintessential illustration that human-bacterial co-evolution not only happens at the host-microbiota
stage (like it was discussed in the previous subsection), but also at the host-pathogen level [27]. This
host-pathogen relationship can be perceived as an everlasting biological arms race between microbial
pathogens and humans, on which, rounds after rounds, pathogens develop new attack strategies, in
the shape of VFs, and hosts counter defend these offensive strikes, through means of immunological
innovations. This drives forward co-evolution on both parts, and ensues biological novelties [28].
Construing on the highlighted relationship, it comes as logical to ascribe infection as a property of the
interaction between the host and the bacterial pathogen, being that non-achievement of infection is as
much of a host feature as it is also an attribute of the foregoing pathogen [29]. Recollecting the host
specificity that V. cholerae displays, it’s only rational to ground that failure to infect species other than
its host (i.e.: other than humans) might well be the outcome of a lengthy evolutionary process that lead
to the specialization of this particular bacterial pathogen on its very own source host species [29]. Like
V. cholerae, many other bacterial pathogens are exquisitely suited to exploit their designated host. Their
ecological niche becomes predefined by the biochemical milieu the host has to offer, in this case the
nutrient rich environment of the human gut [30]. As so, bacterial pathogens are selected on the basis
of exhibiting environmental responses on their side, as well as molecular traits that confer adaptation,
which in due course, if successful, allow them to persist within the host [30]. One of the main selective
pressures that continuously shape the phenotypic behavior of bacterial pathogens is the host immune
system. Host immunological responses, following contact with a bacterial pathogen, are themselves
adaptive in nature, and as such, they seek to neutralize or restrict bacterial replication (i.e.: proliferation).
Therefore, bacterial pathogens deemed successful must either avoid or adapt to the host’s ever-evolving
immune defenses. Anyhow, in order to persevere within a niche over extensive periods of time, the
pathogen must be able to survive within the individual host and also be apt to infect other hosts. To
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achieve ecologic success (i.e.: persistence in its niche within the host population), bacterial pathogens
require mechanisms that provide them with survival skills within their designated hosts, and transmission
between the latter [30]. These mechanisms are, once again, designated as virulence factors (VFs).
Bacterial pathogens are in a general sense, a true scourge on humanity. Yet they fall nothing short
of remarkable from the bacteriological viewpoint, as they can be termed professional in their capability
to display virulent behavior, withstanding the presence, and actions, of either innate or acquired host
defenses, and still be able to cause damage as well as induce a disease-state on their host [31]. In
1996, Stanley Falkow pointed out that the main aptitudes required of a pathogenic bacterium in order
to be successful in its endeavors are (i) to enter the host body; (ii) to secure an exclusive niche; (iii)
to evade or undermine the host’s immune system (innate or acquired) responses, as well as overthrow
other competing microbes; (iv) to attain indispensable nutrients to its survival and/or proliferation; (v) to
reproduce and/or persevere; (vi) to cause damage and/or to induce a disease-state to its host; and finally,
(vii) to exit the present host while still being able to cause infection to new susceptible hosts [32]. On a
side note, despite the fact that the summary authorship of these bacterial pathogens’ core competencies is
usually attributed to Falkow, it was Smith who many years ago, conceived and advanced a first synopsis
of these basic concepts, still valid as of today [33].
Notwithstanding this brief curiosity, one can further realize that virulence genes – which after
being translated into protein are deemed virulence factors (VFs) or virulence determinants – genetically
encode the core competencies needed of bacterial pathogens. These determinants are molecules (e.g.:
proteins) produced by the former microbes with the intent of overturning core biological functions of
the host. Along these lines, the pathogen aims at modifying basic functions of the host, as to uphold
its survival and/or propagation. This overturn is frequently a product of the characteristic interaction
between the pathogen’s VFs and proteins encoded by the host, as well as various other molecules present
within the host’s system [31]. Subversion of the host’s homeostasis, if successful, results in infection and
sometimes a concomitant disease state, in which both the host and the infection-causing pathogen engage
in a battle for survival. Just as the host possesses refined immunological responses against infection –
evolutionarily conserved throughout millions of years [34] – the infection-causing pathogens also bear
correspondingly intricate molecular mechanisms to offset, and further along, overturn the host immune
responses set to neutralize them [35]. This vast arsenal of molecular machineries assists them in the
achievement of their ulterior goals (e.g.: subsistence; propagation), bringing to mind that the ownership
of such mechanisms (i.e.: VFs), encoded within the pathogen’s genome, is the determining factor that
allows us to tell apart virulent microbes from non-virulent ones [31]. Hence, the degree of pathogenicity
of a certain pathogenic species can be attained by its relative abundance of VFs encoded within the
pathogen itself, as well as their function regarding the host-pathogen relationship.
The contribution of a specific gene to a bacterial pathogen’s virulence can be established in the
light of the molecular Koch’s postulates [36]. Falkow established these postulates in 1988, which
were based on the original Koch’s postulates. The original Koch’s postulates were formulated as to
pinpoint the causative relationship between a probable pathogen and a specific disease. For purposes of
clarification, the molecular Koch’s postulates, as originally established by Falkow are quoted as follows:
(i) ”The phenotype or property under investigation should be associated with pathogenic members of
a genus or pathogenic strains of a species”; (ii) ”Specific inactivation of the gene(s) associated with
the suspected virulence trait should lead to a measurable loss in pathogenicity or virulence”; and (iii)
”Reversion or allelic replacement of the mutated gene should lead to restoration of pathogenicity” [36].
Furthermore, a given gene is not required to fulfill all three postulates, but its relative contribution to the
virulence of a particular bacterial pathogen can be acknowledged as bearing more weight if it is present
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in the latter but absent from closely related non-virulent bacteria (e.g.: different strain); if rendering
the given gene inactive (e.g.: by means of mutation) results in loss of the corresponding virulence
mechanism; and if by replacing the inactivated gene with an exact copy of the original one results in
rehabilitation of the virulent phenotype belonging to the preceding bacterium [37]. Virulence genes
are frequently found on transmissible genetic elements such as bacteriophages (viruses that infect and
replicate exclusively inside bacteria), plasmids (small, circular, double-stranded DNA molecules that
are independent from the chromosomal DNA), and transposons (DNA sequences that can change their
position within a genome)[32]. In addition to the previous, virulence genes are also found within the
bacterial chromosome, were they often appear clustered together in contiguous domains that go by the
name of pathogenicity islands [38]. These clusters usually enclose sets of specific genes, the translated
products of which contribute to a respectively specific virulence function, just as the main aptitudes
required of pathogenic bacteria as summarized by Falkow [32]. Bacteria, unlike multicellular eukaryotic
organisms, can exchange genetic information between dissimilar taxa in diverse environments through
means of a process termed horizontal gene transfer (this process shall be discussed in greater detail
in the following subsection) [31,39]. Horizontal gene transfer (HGT) has been implicated in a swift
and broad dissemination of virulence mechanisms amongst diverse pathogens, such as those encoded
within pathogenicity islands that encircle analogous genes and perform similar functions [31]. Another
important aspect that concerns virulence genes is that they do not exhibit constitutive expression in a
regular fashion, but are alternatively only expressed after establishing contact with the host, or after
invasion of the latter [40]. Moreover, the expression of these genes in the host (i.e.: in vivo) is mainly
dependent on the pathogen’s capacity to perceive its surrounding environment and recognize that it has
established contact with the host [31].
A predominant topic in the abiding discussion of bacterial pathogenesis is that most virulence
conferring mechanisms act by subverting host biological processes, and its consequent homeostasis [41].
And, as previously explained, these virulence mechanisms, conferred upon bacterial pathogens as a
result of the expression of virulence determinants, can be succinctly classified according to the core
competencies they grant to the bacterial pathogen in question, like those summarized by Falkow [31,32].
Despite the fact that there are various ways of classifying virulence mechanisms and VFs, the present
dissertation will make use of a broad classification focusing on the main types of both. As such, VFs
can be broadly classified by five different main virulence mechanisms: (i) adhesion; (ii) invasion; (iii)
secretion systems; (iv) toxins; and (v) nutrient acquisition (of which only iron acquisition systems shall
be disclosed) [42]. However, despite the fact that the present dissertation shall resume all five main
virulence mechanisms, only adhesion, secretion systems, and iron acquisition will be examined in greater
detail.
It is well established that an essential stage in any given bacterial infection is the capacity to adhere
to the surfaces in contact with, or enclosed within the host, bearing in mind that a prospective pathogenic
bacterium can also adhere to abiotic materials, such as those essential for life support of critically ill
patients (e.g.: endotracheal tubes). This peculiar characteristic has been thought to be involved in the
dissemination of nosocomial infections [43]. Therefore, most bacterial pathogens need the ability to
attain intimate contact with host surfaces (e.g.: extracellular matrix) in order to achieve prosperous
colonization, and wherefore induce a disease-state. The VFs responsible for carrying out such tasks
are commonly named adhesins [42]. Adhesins can fall into two particular functional categories: initial
contact and/or colonization of the surfaces enclosed within the host through receptor-specific interactions
with host cell receptors; and close bonding of the bacteria with host cell surfaces – event which ultimately
leads to following invasion [31]. Bacterial adhesins show refined affinity for target molecules produced
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by the host such as enzymes and immunoglobulins (key proteins of the host acquired immune system)
[44]. This extraordinary level of precision is species and tissue specific, depending on the bacterial
adhesin that is brought into play. The latter can be witnessed in several strains of enteropathogenic
Escherichia coli, which express adhesins that only adhere to the intestinal epithelium of humans and pigs
[45]. Minding the fact that a sole bacterial pathogen may express a vast array of virulence-associated
adherence mechanisms, and that VFs implicated in adhesion to the host may play other roles in
pathogenicity as well, the part a specific adhesin plays in the infection process of the host can be strikingly
difficult to ascertain [42]. Regardless of the previous hindrance, two principal adhesin groups shall be
approached as archetypes of typical host-pathogen adhesion mechanisms, the first being the type IV
pili (T4P) multi-functional adhesins. Structurally speaking, type IV pili adhesins can be construed as
polymeric molecular complexes, composed of thousands upon thousands of pilin protein subunits, which
together compose utterly thin filaments, named pilus, that stand a few microns in length [46]. Type IV
pili have been credited with several virulence related traits, including surface migration, biofilm (groups
of bacteria stuck together being usually attached to surfaces) production, adhesion, avoidance of host
immunological responses, signaling between individual cells, DNA transformation and the attachment
of bacteriophages [46]. Concerning type IV pili adhesion properties to the host-cell epithelium, one can
expose as an example that the expression of the type IV pili complex is required in the commencing
stages of infection undertaken by the pathogenic species of Neisseria spp. (a wide genus of bacteria that
thrive in the mucosal surfaces of several animals) in order for it to be capable of attachment to human
epithelial cells [46]. The pilus receptor has been conjured to be the glycoprotein CD46, which spans the
cellular membrane of all known human cells except erythrocytes (red blood cells). This last glycoprotein
is known to take part in the activation of the immune system’s complement (an enzymatic cascade that
recruits antibodies and phagocytic cells) [47]. The second group of adhesins to be considered here
as an important virulence conferring mechanism of adhesion are fibronectin binding proteins (FnBPs).
Fibronectin (Fn) presents itself as a 440-kDa glycoprotein that settles amidst the extracellular matrix and
bodily secretions of animals. It was the first extracellular matrix protein confirmed to act as a substrate
for the adhesion of eukaryotic cells namely through the membrane-spanning receptor proteins called
integrins [48,49]. On the pathogen’s side, fibronectin binding proteins comprise a subclass of bacterial
surface adhesins that bind to the host protein fibronectin [48]. Acknowledging the fact that these proteins
comprise a whole subclass of adhesins, one can fathom that their structure varies depending on the
bacterial pathogen species being taken under consideration. Since most of the knowledge pertaining
to bacterial FnBPs has resulted from the study of proteins belonging to the Gram-positive bacterial
pathogens Staphylococcus aureus and Streptococcus pyogenes, the first will be taken as an example [50].
In the former bacterium, one of the two most studied fibronectin binding proteins (FnBPA) is structurally
comprised by two binding domains identified so far [51]. It has been established that the characteristic
interaction between S. aureus FnBPs and the host’s fibronectin, which lies within the extracellular matrix,
is able to expedite the binding of the bacterium to host cell surfaces by taking advantage of fibronectin
proteins previously bound to the host cell integrin α5β1 [52]. The binding of S. aureus FnBPA to human
integrin α5β1 by means of the previously explained process has also been shown to facilitate bacterial
invasion of host cells [52]. A more recent study has further determined that biofilm formation in a S.
aureus methicillin resistant strain is essentially reliant on the activity of FnBPs, thus reinforcing the
multipurpose abilities inherent to this kind of VF [53].
Healthy host epithelium poses as a highly efficient barrier to bacterial pathogenic invasion [31].
As such, an ability to infiltrate intact epithelial surfaces proves itself to be an essential trait for many
specialized pathogenic bacteria, as it has been thought that invasive measures undertaken by bacterial
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pathogens end up providing a sheltered cellular milieu for the bacteria to replicate or persist upon [42,54].
Contrastively, in pathogenic bacteria that are not that specialized in terms of invasiveness, their only
means of doing so depends on wounds or defects in the host epithelium (e.g.: peritonitis resultant of
prior perforation of the intestinal tract) [31]. Equivalently to the connotation bestowed upon VFs that
confer adhesion mechanisms to the bacterial pathogen in question (i.e.: adhesins), the corresponding
VFs that render a specific bacterium able of invasive properties are termed invasins. Anyhow, pathogenic
bacteria capable of crossing intact epithelial surfaces mainly do so by means of breaching through cells
(i.e.: transcellularly), rather than between them (i.e.: intercellularly). Transcellular invasiveness is either
initiated by the host epithelium cells or due to pathogen resourcefulness. Pathogen initiated invasion
happens through subversion of host innate cellular mechanisms, leading to the consequent internalization
of the former [31]. One such example is the internalization of the enteropathogenic bacteria Shigella
flexneri. This bacterium produces and later secretes an invasin, named IpaB, which in due course
disrupts the phagosome (a vacuole that contains a particle enclosed within part of the cell membrane)
and allows the bacterium to break away freely into the cytoplasmic space [55]. The same bacterium
also produces a protein (IcsA) located at its rear pole, that’s responsible for initiating actin (a globular
microfilament-forming protein, present in almost every eukaryotic cell) polymerization, thus enabling S.
flexneri to move throughout the host cell cytoplasm, following penetration of neighboring cells, aiding
in this way the circumvention of host immune responses, and further tissue invasion [56].
Bacterial pathogen’s secretion systems are without a doubt an extensively studied subject in the
field of bacterial pathogenesis, being that the vast majority of bacterial VFs are either located on the
bacterial cell’s surface, or secreted by the former systems [42]. Secreted VFs can portray many roles
in the promotion of bacterial pathogenicity. These roles vary between the enhancement of adherence
to host cells, to the scavenging of nutrients present within a niche, to direct intoxication of host cells
and further disruption of their native functions. A vast amount of bacterial pathogens use specialized
protein secretion systems as to secrete VFs directly from their cytoplasmic milieu into host cells or
the host environment [57]. Some of the systems pertinent to secretion are outstandingly homologous,
not to mention that various other VFs that strike as seemingly unrelated often share common transport
mechanisms. The trend seen up to this moment in naming secretion systems as virulence mechanisms, or
more generally, as indispensable mechanisms to any bacterial lifestyle, has led to their classification into
functional groups according to the transport pathways employed [42]. In this fashion, and according to a
recently published review from the authorship of Erin R. Green and Joan Mecsas [57], the secretion
systems functional groups established so far range from type I (T1SS), to type VII (T7SS), also
comprising: Sec, Tat, SecA2, Sortase, and the Injectosome [57]. However, it has also been proposed
that yet another system, the extracellular nucleation-precipitation (ENP) pathway, to be renamed as
the type VIII secretion system (T8SS) [58]. Likewise, some of the Gld and Spr proteins originally
titled as the Por protein secretion system (PorSS) – characteristic from the phyllum Bacteroidetes –
have been recently titled as the type IX secretion system (T9SS) [59]. Nevertheless, not all of the
secretion systems considered thus far are common to both Gram-negative and Gram-positive bacteria.
Perhaps the two most relevant secretion systems, taking this introduction’s purpose into account, are
the type III secretion system (T3SS), and the type VI secretion system (T6SS), being aware that they’re
only found in Gram-negative pathogens. The T3SS is commonly depicted throughout the literature
as a “needle and syringe”-like mechanism, due to its structure and also due to the fact that it allows
Gram-negative bacterial pathogens to secrete a myriad of substrates across both the inner and the outer
bacterial cell membranes, and sometimes directly into host’s cells, fact which has led it to being referred
to as injectisome [57,60]. The latter shouldn’t be confused with the Gram-positive’s Injectosome,
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proposed to possess an analogous function, yet an unrelated structure, to that of the T3SS and T4SS of
Gram-negative pathogens [57]. Nonetheless, the T3SS, or moreover the injectisome has been depicted
as an analogous mechanism to that of the bacterial flagellum [60,61]. Even though both mechanisms are
structurally and functionally different, they both comprise conserved machinery for protein transport,
which led some authors to classify the bacterial flagellum as a T3SS mechanism [60,61]. In opposition
to translocation-associated type III secretion systems (i.e.: injectisomes), the flagellar T3SS secretes
almost exclusively components of the flagellum to the extracellular environment. Nevertheless, there are
reports of virulent factors being secreted by this type of apparatus [62,63]. Concerning the structure of
the T3SS from the viewpoint of a translocation-associated mechanism, it comprises three core units: a
base complex, the needle component, and the translocon [57]. In animal pathogens, the T3SS needle
component has an inner hollow core through which enables unfolded proteins to be transported [57,61].
Following contact with a host cell, believed to be sensed through the needle, the translocon and tip
proteins create a channel through which these proteinaceous substrates are translocated. Regardless
of the assumptions on how this mechanism works, more experimental evidence is needed to ascertain
the mechanism by which translocation occurs [57]. Nearly all Gram-negative bacterial pathogens that
comprise type III secretion systems mainly use them to transport effector proteins (VFs involved in
the subversion of normal host cell functions) across a target host cell membrane [57,60]. As such,
this secretion system plays an elaborate part in the pathogenesis of many bacterial genera known to
be virulent, such as Yersinia, Salmonella, and Shigella [61], where the injection of protein effectors
allows such pathogens to supersede host native cellular processes, enabling the preceding bacteria to
settle an infectious niche, being it within the host cells or amongst host tissues [57,60]. Moving on
to our next topic of discussion, we find ourselves with the T6SS, one of the last discovered secretion
systems [57]. This secretion system has been reported to be reasonably well conserved amongst a broad
number of Gram-negative species of bacteria, where its main function is to translocate proteins straight
into targets, namely host cells and other competing bacteria, resembling a “firing” motion akin to the
mechanism behind contractile bacteriophage tails [57,64]. Acquainting with the fact that the T6SS was
only identified as of 2006, there are still many underlying factors regarding its structure and putative
functions that are unknown as of today [57]. It was firstly identified as a new secretion system directly
involved with pathogenicity in Pseudomonas aeruginosa and V. cholerae [64], being only later proposed
that it also served other functions such as the mediation of interbacterial interactions, either intra- or
inter-specific [64,65]. Type VI secretion systems are very large complexes, that can encode as far as 21
different proteins within a single contiguous gene cluster, thirteen of which seem to be conserved in all
type VI secretion systems, where they are believed to play a structural part in the secretion machinery
[57,65]. Structurally speaking, the T6SS is believed to be made of two main complexes in association
with additional cytoplasmic elements: an assembly present in the membrane, including two proteins
homologous to bacterial type IV secretion system determinants, and an assembly whose components bear
a structural resemblance to the sheath, tube and tail spike proteins present in bacteriophages [65]. These
two assemblies cooperate by an unknown mechanism in which, the contraction of the bacteriophage-like
sheath structure drives an inner tube terminated by a membrane-puncturing spike against a target cell
[64]. Thus translocating effector proteins across the envelope of the bacterial cell in question, and then
farther through the outer membrane of a target cell [65]. Although T6SS is believed to be directly
implicated in bacterial virulence, some authors propose that the role T6SS plays in the latter might quite
simply be that of enabling bacterial pathogens to compete more efficiently with the host microbiota [65].
All of the above stated in regards to type VI secretion systems, namely its widespread presence and
mediation of interbacterial interactions, has fueled a deep interest in this peculiar secretion system, and
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its fascinating mode of action [64].
Many pathogenic bacteria secrete VFs in the form of toxins. These are potent substances, usually
under the form of enzymes, which are more than enough to dictate the outcome of an infective process.
The major symptoms of a disease caused by a particular toxin-producing pathogen can be witnessed by
the sole injection of modest doses of the purified toxin being considered, substantiating their relevance
in bacterial pathogenicity [42,66,67]. These VFs may be directly or indirectly toxic to host cells,
phenomenon that has led to their classification into functional groups according to their respective mode
of action [66]. It has been known for some time that a specific functional group of toxins, the exotoxins,
are for the most part secreted bacterial enzymes, that kill host cells at deftly low concentrations [42].
Aiming our attention at exotoxins, it has been reported that the foregoing toxins can be administered
to host cells via the routes by which secretion systems operate, like the previously described T3SS
[68]. Exotoxins can target distinctive host cell types, however some explicitly target macrophages and
neutrophils (key cells of the human innate immune system) directly undermining host innate immune
responses. Providing in such a way a convenient environment for active proliferation and inferable
perseverance of the pathogen [67]. This is the case with two toxins secreted by Bordetella pertussis
(the pathogen behind whooping cough), pertussis toxin (PT) and adenylate cyclase toxin (ACT). Being
observed in murine models that this “dynamic duo” displays completing purposes in the pathogen’s
virulence, attacking host immune cells distinctively [69]. PT is thought to act mainly whilst infection is
still beginning to settle, by recruitment inhibition of host innate immune cells. On the other hand, ACT is
thought to attack macrophages and neutrophils at a later stage, thwarting phagocytosis and the posterior
destruction of bacteria as an end result [69].
As for the last virulence mechanism to be discussed, we find ourselves with undoubtedly one of
the most fascinating virulence conferring systems reviewed so far: bacterial iron acquisition systems.
The human body poses as a bountiful reservoir of essential nutrients, one of them being iron (Fe), taking
the fourth place as one of the most abundant elements in our planet’s crust. It’s also the most plentiful
transition metal present in the human body [70], minding that in bacteria, it plays an imperative role
in a vast assortment of physiological processes, such as being the cofactor of many enzymes, being
involved in DNA replication and transcription, as well as central metabolism in general [71]. Likewise,
it’s only rational to ascertain that countless bacterial pathogens have co-evolved with their host as to
exploit this valuable resource [70], which although being the most represented transitional metal within
the latter it’s still classified as a micronutrient, being available in very low concentrations. As such,
most bacterial pathogens use these low iron concentrations as a hint to trigger the activation of certain
VFs [42], especially the ones that shall be addressed as follows. According to a very recent review
authored by Jessica R. Sheldon and colleagues [72], the mechanisms by which pathogenic bacteria
acquire iron within their mammalian host include: (i) the extraction and/or capture of heme (protein
cofactor consisting of a ferrous – Fe2+ – cation incorporated within the center of a heterocyclic organic
ring called porphyrin) associated iron from hemoproteins present in the host through the usage of either
proteins secreted by the bacterium or receptors present in the cell’s surface; (ii) uptake from iron-binding
blood plasma glycoproteins (e.g.: transferrin and lactoferrin) through binding proteins specific of the
bacterium’s cell surface or by means of siderophore (chelating compounds with high-affinity for iron)
secretion; and (iii) the obtainment of free inorganic iron promoted by ferric (Fe3+) iron bacterial intake
proteins (i.e.: reductases and associated permeases) [72]. From all the formerly pointed iron acquisition
mechanisms, the ones that comprise heme as a target are particularly preferred by pathogens, mainly
because heme amounts to roughly 75% of the total iron available within the host [72]. However,
heme is consistently complexed with hemoglobin inside host erythrocytes. Thus, pathogenic bacteria
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have evolved ways to capture heme from within red blood cells, for instance, the active secretion of
hemolysins: exotoxins that cause the disruption, or lysis, of erythrocytes, via destruction of their cell
membrane [73]. After the disrupted erythrocytes have released their hemoglobin to the extracellular
milieu, it stands as finally available for further capture by bacterial pathogens able to express specific
heme/hemoglobin-binding proteins [72]. A few bacterial pathogens, acquire extracellularly available
heme by synthesizing, and later secreting, soluble heme-binding proteins known as hemophores, being
the latter able to appropriate free heme as well as extracting it from host expressed hemoproteins
[72,74]. This salvaged heme is transferred later on to specific heme-binding receptor proteins. These
heme-binding receptor proteins are either localized on the outer membrane, or on the bacterial cell
wall, in case the pathogen is Gram-negative or Gram-positive, respectively [72]. Two major types
of hemophores have been reported until now, one pertaining to Gram-negative pathogens (HasA-type
hemophores), and the other to Gram-positive ones (near iron transporter – NEAT – domain-containing
hemophores) [72]. Another widely used mechanism of iron acquisition is the secretion of siderophores
by bacteria. Albeit siderophore production is a well-established virulence mechanism, it can be found
as an iron-scavenging tactic throughout the prokarya domain [42]. Despite this generalization, one
should regard siderophore use by pathogenic bacteria as a relevant virulence-conferring mechanism.
Siderophores are small iron chelating molecules secreted by bacteria as to bind Fe3+ with a higher
affinity than that of iron-binding blood plasma glycoproteins [75]. Even though siderophores are
usually small and characterized as possessing low-molecular mass, they’re still too large to pass through
non-selective porins (beta-barrel proteins spanning a cellular membrane that act as a pore for the diffusion
of molecules) of Gram-negative bacteria. Taking this case into account, the transport of siderophores
comes as energy-dependent, mediated by the activity of specific porin receptors, especially those that
are TonB-dependent (a family of beta-barrel proteins) [70]. Gram-negative bacteria lack ATP and ionic
gradients in their periplasmatic surroundings, rendering them unable to drive the transport of molecules
across the outer membrane while making use of these gradients. Because of this deterrence, they rather
rely on energy originating at the inner membrane from the proton motive force. This energy is later
harnessed by a specific protein mechanistic complex (the TonB-ExbB-ExbD system), in order to mediate
active transport across the outer membrane. Meanwhile, in the periplasm, substrate binding proteins
(SBPs), belonging to the ATP-binding cassette (ABC) transporter family – in this particular system –
identify the siderophore-associated Fe3+ complex, and conclusively commute it to the respective ABC
transporter. SBPs are expressed by Gram-positive bacteria as well, although being membrane-bound.
Just as the siderophores reach the bacterial cytoplasm, the siderophore-associated Fe3+ is freed from the
complex by means of chemical reduction to Fe2+, or through the siderophore’s subsequent enzymatic
degradation, culminating in the availability of unbounded Fe2+ to be used as a nutrient by the pathogenic
bacterium [70].
1.3 Antibiotic Resistance
Human beings have been battling pathogenic bacteria with the aid of antibiotics for nearly 70
years, ever since the accidental discovery of the very first true antibiotic – penicillin – by Alexander
Fleming in 1928, and it’s ensuing mass production in 1942 [76]. Although some antibiotics had
been discovered as of 1928, penicillin was deemed the first true antibiotic [76], since it possessed
bactericidal (killed bacteria) properties, as opposed to bacteriostatic (inhibit the growth of bacteria)
ones. As thoroughly discussed throughout the literature, antibiotics came into existence as a wondrous
remedy, being acknowledged as one of the most successful drugs ever developed [77-79]. Besides
11
allowing the treatment of infections, the broad use of antibiotics made the implementation of novel
clinical practices possible. Procedures like induced immunosuppression following transplantation or
anticancer chemotherapy, massive surgery, and even catheterization of patients in intensive care units,
are now feasible and commonplace. These patients are more susceptible to infections, meaning that
these procedures can be safely implemented as long as infections are able be treated or prevented
[79]. All antibiotics, or antibacterial drugs to be more precise, discovered thus far, can be succinctly
classified according to their action’s mechanism towards bacterial growth or physiological processes
in general, and also to whether they exhibit bacteriostatic or bactericidal abilities accordingly. Being
faithful to such classification scheme – and for clarification purposes only – we have antibiotics that
induce (i) inhibition of cell wall synthesis – β-lactams (e.g.: penicillin), daptomycin and glycopeptides
(bacteriocidal); (ii) inhibition of DNA synthesis – fluoroquinolones, metronidazole (bacteriocidal); (iii)
inhibition of protein synthesis – macrolides, lincosamides, streptogramins, chloramphenicol, ketolides,
oxazolidinones, tetracyclines and aminoglycosides (only the latter are bacteriocidal); (iv) cell membrane
binding – polymyxins and lipopeptides (bacteriocidal); (v) inhibition RNA synthesis – rifamycins
(mainly bacteriostatic); (vi) and those that inhibit folate (a member of the vitamin B complex) synthesis
– trimethoprim and sulfonamides (bacteriostatic) [80,81].
Unfortunately, it soon became quite clear, right after the discovery of each of the formerly
introduced classes of antibiotics, that some bacteria were developing resistance to them. Even though
antibacterial drugs consistent rate of discovery had been mitigating this drawback for quite some time,
during the past 50 years the pace at which they have been discovered has slowed down substantially,
leaving us with an ever-increasing legion of antibiotic-resistant bacterial pathogens [77,78]. As such,
acquisition of resistance by bacterial pathogens has compromised not only the treatment of the respective
infections they cause, but also the safe implementation of numerous clinical practices that we have
been taking for granted [79]. In light of microbial ecology and evolution, antibiotic resistance (AR)
in bacterial pathogens can be defined as an adaptive trait, acquired after imposing selective pressures,
consequential with prior introduction of therapeutic antibiotics into the pathogen’s environment [78]. It
goes without saying that not every antibiotic resistant bacterium is pathogenic; just as not every pathogen
is antibiotic resistant. However, the aim of this present subsection is to focus on antibiotic resistant
bacterial pathogens.
Drug-resistant strains first appeared in nosocomial environments – the very source of antibiotic
administration. And although there are reports of sulfonamide-resistant S. pyogenes emerging in military
hospitals as soon as the 1930s, it wasn’t until the 1940s that penicillin-resistant S. aureus defied civilian
hospitals in London, shortly after the introduction of this drug [80]. Nowadays, the greatest threat
mankind faces concerning AR, is the one posed by multidrug resistant (MDR) bacterial pathogens,
so-called superbugs [77,80]. In 2007 Gerard D. Wright suggested that it appears to be at least two
distinctive classes of superbugs: the first enclosing well-known pathogens, many of which belong to the
same genera, and even species, to that of the common human microbiota. These bacteria have undergone
acquisition of AR genes, and frequently display increased virulence as well [77,82]. The foregoing
class is thus characterized by bacterial pathogens, such as methicillin-resistant S. aureus (MRSA),
and multidrug resistant E. coli. Minding that the former is usually sub-classified as either community
associated MRSA (CA-MRSA), or health-care (hospital) associated MRSA (HA-MRSA), according to
the epidemiological provenance of the infection, respectively [83]. The second class, however, encloses
opportunistic pathogens, frequently of environmental origin, usually taking advantage of enfeebled or
immunocompromised hosts. Said bacteria often include well-known opportunists like Acinetobacter
baumannii, Burkholderia cepacia, P. aeruginosa, and Stenotrophomonas maltophilia [77]. In order to
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better understand the very nature behind AR, one should be acquainted with its origins, and how this
widespread phenomenon came into existence.
AR has been proclaimed to be an ancient characteristic amongst bacteria, predating the very
first anthropogenic discovery, and therapeutic use, of antibacterial compounds by millennia [84,85].
This argument reinforces the notion that the wide environmental dissemination of AR elements is
inconsistent with their relatively recent emergence, advocating instead the hypothesis of a rich natural
history of AR [84-86]. Such a bold and startling statement can be succinctly explained through the
lens of microbial ecology. As ulteriorly mentioned, spatially organized microbial communities have
originated as soon as 3.25 billion years ago [2]. Yet, bacteria have been around much longer than that,
taking into account that their origins date as far as 3.8 billion years [86]. Bearing in mind that a great
deal of antimicrobials used as therapeutic agents are produced by environmental microorganisms (e.g.:
Actinomycetes) [87], and that the genetic divergence of antibiotic-producing gene clusters places the
origins of the former natural products at least hundreds of millions of years ago [88], we can conclude
that bacteria have been under direct or indirect exposure to naturally-occurring antibiotics during an
equal time period [86]. Furthermore, antibiotic-producing microorganisms must attain mechanisms as to
deflect the very activity of the antibacterial compounds they produce; otherwise they would succumb to
these toxic compounds, along with all other susceptible microorganisms [89]. These genetically encoded
mechanisms of deflection are nothing more than resistance genes, which can be later transferred to human
pathogenic bacteria, as well as other bacteria present in the same niche, in addition to the possibility
of also being a product of independent evolution underwent by the former [79,86]. Corroborating
on the first notion, we have that genome analysis of antibiotic-producers has shown the presence of
genes pertaining to the same functional families as those that confer resistance to current populations
of human bacterial pathogens [79,89]. Indeed, several functional metagenomic studies have proven that
AR genes are disseminated throughout any studied microbial ecosystem, being able to confer resistance
upon their exchange and further expression in a heterologous host [79,89,90]. Such is the case with
the soil [89,90] and the human gut resistome [91] (the collective sum of all genes that confer direct
or indirect resistance to antibiotics [77]). This fact pinpoints these environments as potential natural
reservoirs for AR genes. These reports have been considered to be consistent with the emergence of
AR in nosocomial environments, as well as the vastly described widespread dissemination of AR genes
throughout characteristic microbial niches (e.g.: the soil) [84,89,90]. It has also been further predicted
that novel antibiotics will only select for preexistent resistance genes, harbored for millennia within the
resistome of these natural reservoirs [84].
As it can be ascertained from the previous paragraph, AR is far from a novel trait amongst bacteria.
Still, the diversity of resistant bacteria, the global widespread of resistance, and the multidrug resistance
present in single bacterial taxa has been certainly unprecedented and escalating in the past decades
[92]. Regardless of the primordial origins of AR genes, the development and ensuing selection for
generations of antibiotic-resistant bacteria, as well as their wide dispersion in microbial populations
throughout the biosphere, are resultant from decades of ceaseless selection pressures superimposed
by humans on the latter, through means of a brazen use, misuse, and abuse of antibiotic applications
[93]. Strident examples of the formerly stated acts of carelessness are those of antibiotic prophylactic
practices in non-clinical settings such as veterinary medicine, livestock production, animal husbandry,
agriculture, and aquaculture, in addition to medical malpractice, unsupervised self-medication and their
use in household cleaning products [92-95]. These actions don’t come as a natural process, but instead
as a man-made corruption of nature itself, which eventually led to the selection of antibiotic resistant
clones as opposed to susceptible ones all across the biosphere, thus portraying the classical Darwinian
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evolutionary processes of selection and survival [93].
Just as cleverly epitomized by Stuart B. Levy and Bonnie Marshall [80], selection for resistance can
be construed as an equation with two main variables: the antibiotic, that inhibits susceptible organisms
and selects those that are resistant; and the resistance-conferring gene present in microorganisms that
were selected by the antimicrobial drug. In this fashion, drug resistance only comes forth when the
two variables appear simultaneously in a given environment or host, which may in due course lead to
a human health issue [80]. However, selection for resistance reaches way farther than that: if mediated
by the expressed phenotype of a particular resistant variant in a bacterial clone, it not only selects the
bacterial clone itself, but also all genes pertaining to the bacterial clone’s genome and all the mobile
genetic elements (e.g.: plasmids) and vectors contained in the former, as well as the genes contained
within these elements and vectors themselves [79]. As a result, bacteria displaying an antibiotic resistant
phenotype – along with the resistance genes under selection and the phenotype they confer – diffuse this
genetic cohort as long as there are continuous antimicrobial selection pressures, to further exacerbate and
extend the problem across other hosts and environments [80]. One must understand that the repercussions
of the drug selection process can vary according to the geographical scale and quantitative density at
which the antibiotic agent is being employed. If entire populations – whether they are humans, animals
or plants – are imposing selective forces driven by the treatment with the same class of antibiotic,
susceptible strains will have very little advantage within this niche, and as such, resistant strains will
become the most apt to proliferate [80]. Thus resulting in a serious ecological imbalance that culminates
in the emergence of an environmental pool of resistance genes within populations [80,96]. Furthermore,
formulating on the density at which antibiotics are employed, it comes as extremely important to
underline the effects of sub-lethal antibiotic concentrations on the resistance selective process, since these
concentrations are the ones generally operating at natural environment scales, being either from direct
anthropogenic pollution of the latter; those inherently generated by antibiotic-producing microorganisms;
or the sub-lethal antibiotic concentrations present in the body compartments of humans or animals during
the extent of therapeutic administration [97]. Since carrying an AR gene – either chromosomally or
plasmid encoded – has implications in the fitness cost of the bacteria, its only logical to assume that if
there is no selective pressure for AR in a given environment (i.e.: there are no antibiotic producers nor
man-made antibiotic contamination), the toll of carrying such gene casts a competitive disadvantage to
the bacteria in question, as opposed to susceptible bacteria which don’t bear such gene, and consequently
have no fitness cost associated. Nevertheless, this is not the case with our biosphere, since, like previously
outlined, antibiotics are present at diverse concentrations throughout most microbial environments, hence
providing a steadfast selection and maintenance pressure for resistant bacterial populations [93]. Several
publications on the topic pertinent to the aftereffects of sub-lethal concentrations of antibiotics ultimately
reckon that selection of antibiotic resistant bacteria occurs at exceedingly low antibiotic concentrations
[97-100]. On a particularly prominent study [97], selective pressures imposed by three classes of
antibiotics broadly used in clinical practice – aminoglycosides, fluoroquinololes and tetracyclines –
with concentrations down to few hundred-fold below the minimal inhibitory concentration (MIC) of
susceptible bacteria, could select and enrich a specific niche, for resistant ones. This could be partially
explained by the fact that resistant bacteria have indeed a competitive advantage at all concentrations
of a given antibiotic at which the susceptible clones’ growth reduction is larger than the fitness cost of
resistance [100], minding that even at sub-inhibitory concentrations, the antibiotic still exerts a burden
on the susceptible clones.
Our discussion regarding the selection for antibiotic resistant bacteria wouldn’t be thorough if we
didn’t approach how the multidrug resistance (MDR) phenomenon came into existence. Even though the
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exact evolutionary mechanisms that led to the selection of MDR bacteria remain somewhat puzzling, a
few explanations have shed some light on the subject. One intriguing aspect believed to be at the origins
of MDR is that the continuous administration of a single antibiotic, selects for bacteria that are resistant
to several other antibiotics, in addition to that particular one [92,101]. This occurrence suggests the
presence of different resistance-conferring genes on the same mobile genetic elements, including, but
not limited to, transposons and plasmids. Intriguingly, bacteria that already attained resistance to one
antibiotic seem to earn competitive advantage by recruiting additional resistance genes from neighboring
bacteria that share the same environmental niche [80]. Following this train of thought, it should be
mentioned that a study which sampled the resistome of soil-dwelling bacteria, found on an average basis,
that a sole bacterium displayed resistance to 7 to 8 different antibiotics [89]. Accordingly, combinatorial
resistance has been proposed to be a standard phenotype amongst environmental bacteria [77]. This
further ascertains the presence of MDR in opportunistic pathogens of environmental origin, such as
the earlier cited A. baumannii and P. aeruginosa. It has also been further suggested that sub-inhibitory
concentrations of antibiotics as well as multiple antibiotic combinations – frequently used in prophylactic
and therapeutic clinical practice – might bring about the emergence and propagation of novel multidrug
resistant bacterial pathogens via selection for resistance [102]. Notwithstanding all the abovementioned
justifications, one of the simplest explanations for witnessing a never-ending increase in MDR, is that a
single molecular mechanism, encoded by a single gene, may confer resistance to more than one antibiotic
[103]. One such known resistance-conferring mechanism is that of multidrug efflux pumps.
Dwelling on the molecular mechanisms that confer resistance, and analogously to VFs, they
present themselves as the product of resistance genes’ translation into protein. These mechanisms
have been thought to originate from naturally occurring antibiotic producing microbes [87,89], which as
highlighted previously, were developed as a deflection tactic so that the former producers wouldn’t suffer
the same fate as the susceptible microorganisms neighboring them. Moreover, an antibiotic compound
can only induce bacterial growth inhibition, or cell death, upon successful interaction with its target. In
order for this to become possible the antibiotic must recognize the target, and the concentration of the
latter compound must be enough as to achieve successful performance. Additionally, in furtherance of
interacting with their targets, these compounds sometimes need to cross the bacterial cell envelope as well
as be further activated by bacterial enzymes [79]. Therefore, the previous deflection mechanisms must
fend off the modes of action by which antibiotic compounds operate, through elaborate strategies such as
modification of the target (e.g.: through mutation or chemical modification); reducing the concentration
antibiotic that can access the target (e.g.: through decreased permeability or active efflux); chemically
modifying the antibiotic compound; or even protecting the target from the actions of the former
compounds [79,104]. Ultimately leading to acquired resistance to the antibiotic targeting the bacterium in
question. Said molecular mechanisms of deflection (i.e.: resistance determinants), congruently with the
fact of having been extensively studied, can be classified in numerous ways. The most common being
the classification according to which antibiotic they confer resistance to, and/or their functional role
within the bacterium [93]. Focusing solely on the functional role of the resistant determinants, instead
of the specific antibiotic they confer resistance to, and according to the Resfams database developed by
Molly K. Gibson and associates [105], some of the most commonly depicted AR protein families can be
succinctly classified as: (i) acetyltransferases; (ii) antibiotic inactivation enzymes; (iii) β-lactamases; (iv)
gene modulating resistance proteins; (v) glycopeptide resistance proteins; (vi) multidrug efflux pumps;
(vii) nucleotidyltransferases; (viii) phosphotransferases; (ix) quinolone resistance proteins; (x) rRNA
methyltransferases; and (xi) target protection proteins [105]. Without entering into too much detail, the
present dissertation shall disclose ever so briefly how these mechanisms operate, while focusing to a
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greater extent on (two particular families of) multidrug efflux pumps.
We can see as an example that acetyltransferases, nucleotidyltransferases, and phosphotransferases
confer high levels of resistance by chemically modifying the antibiotic compound – through means of
transferring or switching an acetyl group, a nucleotide, or a phosphate group, respectively – ultimately
rendering it unable to successfully interact with its target. On the other hand, β-lactamases and antibiotic
inactivation proteins actively degrade this compound, making use of enzymatic machineries to achieve
such goal [104]. From the former list one can argue that β-lactamases have been the most widely
studied, as well as the ones with greater historical relevance since the very first use of antibiotics,
with the disclosure of penicillinase (a β-lactamase that degrades penicillin) in 1940, just 12 years
after the discovery of its target antibiotic [76,106]. As for function, β-lactamases operate through
hydrolysis of the β-lactam ring (a ring comprised of four atoms, present in all β-lactam antibiotics), thus
deactivating the drug’s antibacterial properties [107]. Moving on to other mechanisms of resistance,
ribosomal RNA (rRNA) methyltransferases for instance, methylate specific amino-acid residues in
various bacterial rRNA subunits, conferring resistance to a wide range of drugs that are rendered
unable of recognizing this site. Such is the case with the erythromycin ribosome methylase (erm)
gene family, whose genes’ products main function is to methylate 16S rRNA and alter the drug-binding
site of macrolides, lincosamides and streptogramins [104,108]. The same can be analogously said for
more loosely classified mechanisms like target protection proteins, glycopeptide resistance proteins,
and quinolone resistance proteins, which also confer resistance by either chemically modifying the
antibiotic’s target – usually the DNA, DNA-associated proteins, or the ribosome – or by interfering
with the antibiotic-target interaction. One such example of the latter mechanism is that of the qnr
genes that encode for pentapeptide repeat proteins (PRPs) [104]. These PRPs act by binding to and
protecting topoisomerase IV (a DNA-associated protein responsible for unlinking DNA following its
replication) as well as DNA gyrase (a DNA-associated enzyme that relieves strain during the unwound
of double-stranded DNA) from the bactericidal action of quinolones [104], being that a relatively
recent study further conveys that PRPs interact with the topoisomerase-quinolone complex after the
binding of the antibiotic, resulting in the release of the quinolone [109]. Gene modulating resistance
comes as a broad classification of various AR determinants, which may play a more indirect part in
resistance. The term “gene modulating” refers to their role as modulators of AR gene expression,
bringing into mind that the vast majority of these so-called modulators can act at the gene transcription,
or translation level. Moreover, their actions can be occasionally induced by the presence of antibiotic
compounds, sometimes at sub-lethal concentrations [110]. A common example of these determinants
is the two-component system VanR/VanS of enterococci, which directly controls the expression of
genes that mediate resistance to vancomycin [110]. This two-component signal transduction system
is composed of a membrane-dwelling histidine kinase (VanS), and a response regulator present in the
cytoplasm (VanR) that acts as a transcriptional activator of many vancomycin resistance genes, including
vanA, vanH, and vanX, amongst others [110,111]. The expression of other AR mechanisms, for instance
multidrug efflux pumps, is not usually regulated by two-component systems, although some exceptions
have been reported, namely that of the AdeABC pump in A. baumannii, which is in due term regulated
by the AdeR/AdeS two-component system [110,112].
Even though AR can be attained through a plentiful array of molecular mechanisms, particularly
those depicted so far, resistance due to active efflux of drugs poses as a mechanism of paramount
importance when it comes to the AR thematic, since a single class of multidrug efflux pumps can confer
resistance to various antibiotics, bestowing a MDR phenotype to the bacterium expressing these efflux
mechanisms [113]. Illustrating on the common mode of action that ultimately confers AR to bacteria that
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comprise these efflux pumps, one can perceive that the latter mechanisms operate by extruding antibiotic
compounds from within the cytoplasmatic milieu onto the extracellular space, after these compounds
had been previously internalized, in an active or passive way, by the bacterium. In this fashion, the
efflux pump-coding bacterium never reaches inhibitory intracellular concentrations of antibiotics, and as
such, becomes resistant to the latter. Albeit these resistance determinants were firstly characterized in
E. coli as being plasmid-borne and assumed to be acquired through means of HGT [114], just like the
majority of resistance determinant-encoding genes reported until then, it soon became clear that these
mechanisms weren’t an exclusive trait of bacteria, nor were they restricted to being plasmid-encoded,
minding that genes encoding for these determinants were later found encoded in the chromosome of
other bacteria and also in the chromosomes of archaea, and even eukaryotic organisms, as duly reviewed
by Jose´ L. Martı´nez and colleagues [115]. It also comes as important to outline that the presence of
multidrug efflux pumps is not circumscribed to antibiotic producers, just as the fact that, in bacteria,
most multidrug efflux pumps encoding genes described insofar have been found to be enclosed within the
chromosome, exhibiting a well-conserved structure, along with a firmly regulated expression [115,116].
In addition to these characteristics, the expression of multidrug efflux pumps is not confined to bacteria
that dwell amidst environments with high antibiotic selective pressures, since most of these pumps
not only extrude antibiotics, but also toxic compounds resultant from human industrial activity (e.g.:
organic solvents derived from petroleum); other antimicrobials, like those produced by plants; bacterial
signaling molecules (e.g.: quorum sensing molecules); and even heavy metals, originated from human
environmental pollution or naturally-occurring in our planet’s crust [115]. Thus reinforcing either the
non-selective nature portrayed by these efflux pumps, as well as their wide dissemination in bacteria
pertaining to non-clinical environments, and partially explaining why the presence of a single class of
these mechanisms can confer resistance to a myriad of different antibiotics. It has been further suggested
that the aforementioned characteristics advocate that the core function of these systems mightn’t have
risen with the purpose of extruding antibiotics used in clinical-practice, considering all the other roles
portrayed by said mechanisms that pose as relevant to bacterial behavior and survival within their natural
ecosystems, including, but not limited to, detoxification from intracellular metabolites, maintenance
of cell homeostasis and intercellular signal trafficking [115]. Notwithstanding the broader functions
exerted by multidrug efflux pumps, and rather directing ourselves towards their categorization, one
can be acquainted with the five families of multidrug efflux pumps that have been described thus
far, according to their structural configuration, number of regions that span the membrane(s), sources
of energy, and substrates: (i) the ATP-binding cassette (ABC) super-family; (ii) the multidrug and
toxic compound extrusion (MATE) family; (iii) the major facilitator super-family (MFS); (iv) the
resistance-nodulation-division (RND) super-family; and (v) the small multidrug resistance (SMR) family
(which is a subgroup of the drug/metabolite transporter super-family – DMT)[113,117]. Only the ABC
super-family and the MFS super-family of multidrug efflux pumps shall be disclosed as mechanistic
examples of AR determinants. Multidrug efflux pumps pertaining to the ABC super-family export (or
import) a wide variety of substances, driven by the energy discharged from ATP hydrolysis, being the
latter process the core feature of this super-family, which stands as the biggest of all paralogous families
of proteins [113,118]. The minimal, yet sufficient, structural organization required of a functional
ABC efflux pump comprises four domains: two ATP-binding domains, and two membrane-spanning
permease domains, taking into account that extrusion systems are either characterized by homodimeric,
or heterodimeric organization, in which one nucleotide binding domain is fused with one transmembrane
permease domain, being usually called half-transporters [118]. As an example of an ABC multidrug
efflux pump, we have the MacB macrolide exporter of E. coli, that exists as a dimer and contains the
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four characteristic domains from all ABC proteins [119]. In the former bacterium, the MacB efflux
pump, which spans the inner membrane, works together with MacA, a membrane fusion protein from
the periplasmic space, and TolC, an outer membrane channel protein. MacA couples ATP hydrolysis
from MacB ATPasic activity by promoting a closed ATP-bound state on the latter, with the transport of
substrates across the outer membrane through TolC, thus establishing a physical link between the ABC
efflux pump (MacB), and the outer membrane channel (TolC) [119]. This complex is usually referred
to as the MacAB-TolC tripartite efflux system that in such a way manages to span both inner and outer
membranes of E. coli [119]. Furthermore, as a second relevant example of an ABC multidrug efflux
pump, MsbA in E. coli, a Lipid-A flippase, plays a role in the biogenesis of the outer membrane by
being responsible for the transport of lipid A across the inner membrane [118]. Resistance conferred
by MsbA in E. coli has yet to be documented. However, MsbA present in Lactococcus lactis has been
reported to confer resistance to erythromycin, an antibiotic from the macrolide class, and showed high
levels of a DNA dye and ethidium export [120]. Conversely to ABC efflux pumps’ mechanistic mode
of action, MFS efflux pumps are secondary active, or passive transporters, only capable of extruding
low molecular weight solutes, via ion gradient or solute osmosis, respectively [121,122]. Even so, both
MFS and ABC super-families of multidrug efflux pumps are recognized as the most prevalent drug efflux
systems in bacteria [118]. E. coli, for instance, has 10% of its genome coding for efflux pumps of the
MFS-type [123]. Members of the MFS were believed to uptake sugars as their primary function [121],
since these proteins’ super-family comprises either uniporters (transport of a single substrate in favor
of the gradient), symporters (transport of a solute and an ion in favor of the gradient), or antiporters
(transport of a single substrate against the gradient) [122], bearing in mind that MFS efflux pumps fall
into the antiporter category [123]. Yet, nowadays it’s well established that the substrates mobilized by
MFS transporters are discrete small molecules such as amino acids, antibiotics, nucleic acids, sugars, and
various metabolites [122]. These efflux pumps are of extreme interest to researchers since they’re easily
able to confer multidrug resistance in critical bacterial pathogens, being well-documented candidates
for therapeutic modulation [122,123]. Concerning their structure, and as a rule of thumb, MFS efflux
pumps have either 12 or 14 transmembrane spanning segments (α-helices) [122]. According to Indrika
Ranaweera et. al. [122], and taking a 12 segment efflux pump into consideration, we can further see that
these segments organize themselves in two bundles, symmetric in structure but asymmetric in function,
named N-terminal (transmembrane spanning segments 1-6) and C-terminal (transmembrane spanning
segments 7-12) domains, respectively. Creating a large central aqueous cavity formed by the elements of
these two bundles as an end result [122]. Likewise to ABC-type pumps, in Gram-negative bacteria, MFS
efflux pumps can also be part of multicomponent systems, like the well-studied EmrAB-TolC complex
of E. coli [123]. Similarly to the ABC-type tripartite system mentioned above, the EmrAB-TolC is
comprised by EmrB (the MFS efflux pump), EmrA (the periplasmic adaptor protein) and TolC (outer
membrane channel), forming a contiguous efflux system that allows direct export of substrates from the
cytoplasm, straight to the extracellular space, thus achieving the same function as the abovementioned
one [124].
So far this present subsection has been discussing the emergence of AR determinants; their wide
dissemination throughout the biosphere; the evolutionary processes by which they’re selected; and the
most notorious molecular mechanisms of AR. But perhaps the most important topic regarding AR was
purposefully left for last. Such topic is that of Horizontal gene transfer (HGT). Outlining a review
penned by Cheryl P. Andam and colleagues [125], HGT can be briefly defined as the exchange of genetic
material between two cells that do not partake in an ancestor-descendant relationship, and contrarily to
parent-to-offspring inheritance, acknowledges almost no taxonomic boundaries amongst bacteria. The
18
genetic material exchanged might be comprised of gene fragments; whole genes; operons (cluster of
genes controlled by a sole promoter – DNA region that initiates transcription); superoperons (operons
that encode complex metabolic pathways); plasmids, and even entire chromosomes [125]. Conjugation,
transformation and transduction are consistently referred to as the three most well studied methods of
HGT in bacteria [126]. Conjugation is the exchange of genetic matter between a donor and a recipient
cell, making use of a conjugation pilus, requiring physical contact between the former cells. Conjugative
plasmids are commonly the mediators of such process, although conjugative transposons are also known
to induce the conjugation process [39]. Transformation is construed as the uptake of “free” exogenous
DNA from the surrounding environment, an illustrious feature of competent bacteria – competence being
defined as the innate ability of a given cell to uptake “free” DNA. Finally, transduction can be seen as the
consignment of genetic material as a consequence of bacteriophage predation, assuming that genetic
material from another host (i.e.: bacterium) has been previously integrated into the bacteriophage’s
genome [126]. After the exchange of genetic material, the recipient cell now possesses additional
molecular information, which can confer a new phenotypic trait, like resistance to a given antibiotic.
Thus, this inherent ability displayed by microbes (e.g.: bacterial pathogens), might pose – in some
particular instances – as a great threat to human health [125]. Taking plasmids as a relevant example,
one can reckon the easiness through which they are spread across heterogeneous bacterial populations
[39], and the fact that such plasmids often code for AR genes [127], and even virulence-conferring ones,
the latter being often associated with cooperative traits amongst the preceding microbes [128]. Another
menace originates from the rapid emergence, mutation, and positive epistasis (interaction between genes)
of AR genes present on disease-causing organisms [129] that might display a MDR phenotype. The
genetic information enclosed therein can be later transmitted to other bacteria, such as those that dwell
within the human body (e.g.: the human gut microbiota [130]), generating possible shifts between
mutualism and parasitism [4,128], and exasperating the AR phenomenon even further. Following the
preceding example, one already knows that the gastrointestinal tract has been revealed to be a reservoir of
AR genes for some time now [91], owing to an optimal blend of conditions that promote the emergence
and spreading of AR genes amongst bacterial populations, namely high cell density [130]. Another
factor is that of HGT, by which resistant mutualistic bacteria may bestow resistance genes upon transient
bacteria that don’t reside within the gut for extensive periods of time (e.g.: pathogens) [130]. For
instance, a study conducted on human volunteers showed that resistance to ampicillin and sulfonamide
was transferred by means of a conjugative plasmid, from one resident E. coli strain, to another E. coli
strain that had been administered [130,131], advocating such hypothesis. This phenomenon has also been
proclaimed to purportedly occur the other way around – from transient pathogens to our microbiota. One
such example is that of a study conducted during an outbreak of Enterobacter cloacae, which showed that
conjugation of a carbapenem resistance-conferring plasmid probably happened between the offending
pathogen and other Enterobacteriaceae present in a patient’s gut microbiota, further spreading to other
subjects [130,132]. Another example is that of a reported E. coli strain that donated a plasmid, encoding
for ampicillin resistance, to another E. coli strain in an infant’s gut [130,133]. The authors of such study
concluded that the selective pressure required as to increase the donor cell density – thus favoring the
transference of the resistance-encoding plasmid to the receiving strain – was provided following the
administration of ampicillin, in order to treat the patient for a urinary tract infection [130,133]. With
the given examples, one can undoubtedly ascertain the preponderance that HGT bears when it comes to
the known dissemination of AR genes, that often seem to find a way to walk hand-in-hand with virulent
bacterial lifestyles.
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1.4 Co-selection Hypothesis
It cannot be overemphasized that one of the major concerns regarding pathogenic bacteria is
their increasing ability to resist antibiotic treatment. Referring back to the previous section, this
overbearing phenomenon has severely hindered our ability to clinically approach infectious bacterial
diseases worldwide [77-79]. Moreover, these ailments are often induced by MDR pathogens, like MRSA
[83], or multidrug resistant Tuberculosis (caused by the Mycobacterium tuberculosis bacterium) [134],
known to reemerge from time to time in a multitude of successive outbreaks throughout the world.
Further reiterating on virulence and AR as deterring factors of human survival, and in spite of the fact that
both are extensively scrutinized themes of foremost importance to microbiology, and medical practice in
general, there have been very few instances where they are conjointly addressed, since they have, for a
long time, been outwardly seen as unlinked phenomena [135].
In 2002, Jose´ L. Martı´nez and Fernando Baquero outlined this fact in a comprehensive review
[135], where they asked if an evolutionary relationship between AR and bacterial virulence is in fact
taking place, focusing on the selective pressures imposed by modern medical practices, by means of
an ever-increasing antibiotic usage, as the main driving force operating on the co-selection of AR
and bacterial virulence. As one already knows, the dawn of therapeutic antibiotics initially precluded
the spread, and quite possibly the evolution of pathogenic bacteria, with the aftermost costly price
of AR emergence [135]. Indeed, from an ecological standpoint, one should also recollect that both
infection-states and antibiotic therapies generate extremely effective evolutionary bottlenecks [30,93],
that in due course prune bacterial diversity, only enabling host colonization to a very selective subset
of highly specialized bacteria able to withstand these stringent conditions [135], bearing in mind the
selective pressures exerted by either the host immune system, antibiotic therapy, or even the two
combined. Martı´nez and Baquero further asserted that virulence and AR can be construed as similar
biological mechanisms of adaptation, which have been selected through a lengthy evolutionary course,
encompassing countless generations, as to grant bacterial survival under the outlined ecologically
stressful conditions [135]. Additionally, even though AR and virulence determinants were developed
on disparate timescales [136], from a biological standpoint they still share common characteristics
nonetheless, such as (i) both being required by bacteria in order to survive under inauspicious
environments [30,80,135,136]; (ii) both being mainly acquired through means of HGT, from other
bacteria [31,127,128]; (iii) direct or indirect interplay between both resistance and virulence-conferring
determinants, with special reference to the part played by adhesion mechanisms and multidrug efflux
pumps in biofilm-producing pathogens [53,136,137]; and (iv) being sometimes controlled by regulatory
systems, which activate or repress the expression of genetic complexes that encompass both types of
determinants [136,138].
Heeding the role HGT plays in the co-selection phenomenon, one can also realize that, in point
of fact, the transference of mobile genetic material has been proposed to be the quintessential genetic
process by which the dissemination, and subsequent co-selection of both virulence and resistance
genes occurs [136]. If we acknowledge a conjugative plasmid as a germane example, coding both
for VFs and AR determinants, one knows that it could swiftly spread across heterogeneous bacterial
communities [39], such as those that inhabit the human gastrointestinal tract. Hence, further reminiscing
on the fact that in bacteria, HGT mechanisms seem to be confined by few, or none, taxonomic barriers
[125], one can picture that this conjugative plasmid becomes widespread within the aforementioned
communities, bestowing the encircled bacteria with a genotype that codes both for resistance and
virulence. Elaborating on this scenario, and ascertaining the preponderance of conjugation on the
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co-selection of these determinants, one should also be acquainted with the fact that this process has been
reported to trigger the bacterial SOS response – bacterial stress response resultant from an abnormal
increase of single-strand DNA (ssDNA), which is often an indicator of DNA damage – known to control
both DNA repair and gene recombination [139]. On a side note, it ought to be mentioned that bacterial
SOS response has been established to be commonly induced by the presence of antibiotics, such as
quinolones which directly inflict damage upon the DNA [136], as well as the fact that sub-inhibitory
concentrations of the former compounds have also been reported to heighten bacterial transcription,
and quite possibly enhance, or favor, the acquisition of favorable traits, through the very process of
gene transfer [99,140]. These low concentrations can be easily achieved due to the misuse of antibiotic
drugs, by means of environmental pollution or prophylactic administration, as accordingly stated in the
previous subsection. In such a way, HGT is hereby prompted through diverse processes like conjugation,
integration and transposition. And even if antibiotics are correctly administered in a clinical setting, the
development of antibiotic gradients is renown to exist, either within a human body, or in an environmental
scope [99].
As to better contextualize the part played by bacterial SOS response in the co-selection process,
one can fathom that ssDNA is produced by several HGT mechanisms, for instance, conjugation [139]. As
such, when conjugation takes place (or when an antibiotic damages bacterial DNA), a sudden escalation
of ssDNA levels follows, being readily detected by the recipient bacterium, which ensues a SOS response,
ultimately leading to gene cassette (mobile genetic element that contains a gene – or genes – and a
recombination site) rearrangements [139]. Gene cassettes are known to often include AR genes, as well
as being usually incorporated within integrative genetic elements called integrons [141]. These elements
can be defined as genetic units that contain determinants coding for site-specific recombination systems,
capable of gene capture and mobilization, such as those comprised by the foregoing gene cassettes
[141]. In this fashion, once a bacterium initiates a SOS response, it up-regulates integron integrases (the
enzymes responsible for the integration of genetic material), that consecutively capture and incorporate
gene cassettes, leading to further rearrangements of the former genetic complexes [139]. The preceding
mechanism can, quite plausibly, drive the acquisition of a MDR phenotype, at least through the agency of
two different events: if one postulates multiple gene cassettes coding for resistance to different antibiotics
being successively incorporated every-time this mechanism takes place; or a sole gene cassette that
encodes, by itself, for a multidrug resistance determinant (e.g.: efflux pumps) [103,142].
Although integrons are not mobile elements by their own nature, they are known to exist in
plasmids and transposons [142], elements that bestow them with mobility. Accordingly, one can reckon
that any given virulence-coding plasmid, containing integrons in addition to the latter determinants,
can easily incorporate multiple AR genes cassettes, via integrase recombination. Along these lines,
this hypothetical plasmid, becomes a vector for the dissemination of both AR and VFs – occurrence
which has already been depicted in the literature [143]. Nevertheless this event can happen the other way
around: a resistance-conferring plasmid can incorporate genetic islands coding for VFs, such as the VCR
(Vibrio cholerae repeated sequences) cassettes, which are prototypical examples of composite integrons
encasing virulence determinants [135,144]. Furthermore, research on VCR clusters has established that
the genetic organization of these elements is akin to that of gene cassettes coding for AR known to be
present in integrons [135,144]. Also, the provenance of VCR islands has been presumed to have risen
from integrase mediated processes, which further advocates on the similar role VCR islands play in gene
capture, when comparing to that of integrons in the procurement of AR genes [135]. Notwithstanding
all these instances, an integron can also be transposon-borne, like briefly mentioned above [142]. And
if one recalls that transposons are mobile elements that can readily change their position within a given
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genome (e.g.: between other mobile genetic elements, like plasmids, and the bacterial chromosome),
one can also acknowledge the suppositional aggravation these genetic elements might exert when taking
the conjoined capture of virulence and resistance-conferring genes as well as their later dispersal to
other bacteria into account – although knowledge concerning the relationship between virulence and
resistance determinants in the same transposon is still lacking, albeit for a few peculiar examples [136].
By the very nature of the processes described thus far, it becomes quite clear that if the same genetic
element codes for both AR genes and VFs, then, co-selection of both types of determinants will surely
ensue, i.e, if a given bacterial population carries these coupled determinants, the selection for virulent
traits (e.g.: through means of selective pressure imposed by the host immune system) will consequently
select for AR determinants; and analogously, antibiotic selective pressure (e.g.: enforced by antibiotic
therapy) will consequently select for VFs [135]. Now, imagining an alternative theoretical scenario,
for instance, concerning the human gut microbiota, in which its residing bacterial population detains a
well-conserved chromosomal gene coding for resistance to a certain antibiotic, resultant from long-term
antibiotic consumption by the host. Amidst this milieu, there might be a transient alien pathogen as
well, containing a plasmid coding for virulence. If this pathogen, through HGT, shares his plasmid
with one bacterium within the gut microbiota, and this bacterium further shares said plasmid with the
rest of the community, this hypothetical community now codes for both virulence and AR, rendering
the bacteria resident therein as potential pathogens. This situation may also happen the other way
around, i.e., the gut microbiota encompassing a resistance-conferring plasmid and then sharing it with
the transient pathogen that chromosomally encodes for virulence, which in due course becomes resistant
to a given antibiotic, being now able to infect other hosts, while portraying both virulent and resistant
traits. One must understand however, that this imaginary situation does not correspond to co-selection
per se, but rather to co-representation of both types of determinants. Yet, there is another setting on
which co-representation of both determinants might arise. Since microbial communities, together with
the environment that surrounds them, can be seen as purported functional evolutionary units [1], if
in the same microbiome there happens to be bacteria whose genome encodes for VFs, whilst other
bacteria encode for AR determinants, when analyzing said microbiome as a whole (e.g.: metagenomic
analysis), a co-representation of both types of determinants might present itself, even though they are
not being encoded in the same bacterium. Nonetheless, acknowledging that these bacterial communities
can be regarded to function as a whole, one can define this type of associations as being indeed of
co-representative nature, being able to later prove themselves as co-selective if the aforesaid mechanisms
of HGT come into play amidst the addressed communities.
In addition, conjugative plasmids have also been reported to induce biofilm production [145],
which itself plays a crucial role in HGT. The very matrix-like structure of biofilms promotes HGT,
especially by means of conjugation. Indeed, the very process of conjugation also ends up stimulating
the production of biofilm structures, given the high cell density and closeness of the foregoing bacterial
cells [136], thus resulting in a feedback loop of sorts. Other HGT processes like transformation also
seem to be required for biofilm formation and further stabilization [136,146]. Biofilms should not be
seen as virulence-conferring complexes per se, minding that a great deal of bacterial populations have
been widely depicted as being found in association with environmental surfaces, throughout numerous
ecosystems, in this type of complex that usually encloses several species [145]. However, some
determinants that lead to biofilm production are known to be VFs, like type IV pili, fibronectin-binding
proteins, and a type IV secretion system which has been established to be a contributor in the formation
of the former complexes, mediating cell-to-cell contact, and by this way, intervening in DNA transfer,
respectively [46,53,136,147]. Still, when in an infectious setting, biofilms are matrix-complexes
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of undeniable importance, conferring outstanding advantages to the pathogens that produce them,
outlining their direct implication in several austere diseases, such as chronic bronchitis, cystic fibrosis,
endocarditis, kidney stones, and osteomyelitis [135,148]. When in this type of setting, biofilms allow
bacterial pathogens to subvert host immunological responses [148], and even confer an indirect resistance
to the actions of several antibiotics, bearing in mind that bacteria growing in biofilms are more resilient
than those that lead a planktonic lifestyle [135], since the actions of the former antibiotics do not affect
bacteria inhabiting the inner layers of biofilms. Moreover, multidrug efflux pumps have also been
acknowledged as one of the main mechanisms that grant AR to biofilm-producing bacteria [137]. Efflux
systems have been thoroughly involved in bacterial signaling – i.e.: quorum sensing – regulation, and
it is well established that quorum sensing controls the expression of numerous VFs, along with biofilm
differentiation [137,149]. Evidence concerning the role of multidrug efflux pumps in biofilm resistance
has been found in several bacteria like P. aeruginosa and E. coli [137]. Several studies have reported that,
in E.coli for instance, biofilms detain higher AR in comparison to planktonic cells, and that expression
of several multidrug efflux pumps was found to increase in biofilms [137,150], just like the genes coding
for the AcrAB-TolC multidrug efflux pump system, which have been proclaimed to be up-regulated
under the formerly mentioned conditions, in addition to exposure to several antibiotics [137]. Without
intending to deviate from the subject at hand, one should also be mindful of the existence of a P.
aeruginosa two-component regulatory system (CbrAB), implicated in biofilm formation, virulence, and
AR [138]. In this regulatory system, CbrA is a sensor kinase, propounded to modulate biofilm formation,
cytotoxicity, and even swarming motility through CbrB regulatory responses, and may likely modulate
AR independently [138]. Now, if one acknowledges all the abovementioned characteristics that are
inherent to biofilms and the processes involved therein, one can therefore ascertain that there is in fact
not only a positive feedback loop between HGT processes – asserting on conjugation as the most relevant
process – and biofilm formation [136], as there also appears to be an interplay between AR determinants
and VFs, working together as to reach the same goal. These instances might very likely favor the
transmission of AR and VFs genes collectively, especially in the presence of antibiotic selective pressures
[136]. Minding that antibiotics might act as to select for bacteria capable of producing biofilms, thusly
broadening the prevalence of reputed infective lifestyles [135], as well as the interrelationships, common
gene regulators, and co-representation of both types of determinants.
As a concluding remark, one can realize that in a world with great availability of antibiotics, and
in some cases, unregulated administration, bacteria and microbiomes are subject to different levels of
antibiotic selective pressure. In this context, we can envisage that for some pathogens, in order to survive
and colonize the host, it is not enough to code for VFs, if antibiotics are present. That is to say that AR
can be viewed as being part of the pathogen’s strategy. Or, from another point of view, under antibiotic
selective pressure, selection of mobile genetic elements coding both for resistance and virulent traits
might occur, resulting in their dissemination within human bacterial communities, such as the human gut
microbiota. Even if these determinants do not find themselves within the same mobile genetic element,
or in the same bacterium for that matter, the co-representation of the former determinants might also
reinforce on the notion of co-selection, given the presence of antibiotic selection pressures.
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1.5 Metagenomics and Bioinformatics
Metagenomics came into existence as an astonishing brave new field of study, following the
post-genomic era. It can be construed as contrastive with genomics, in the way that the latter rather
concerns itself with the study of individual genomes from single organisms, whereas metagenomics
addresses all the genomes, and further genes, from all the microbial representatives enclosed within the
given sequenced sample collectively – recollecting on the notion that designates the aforementioned
collection of genes as a metagenome. This rather recent field, together with the ever-increasing
availability of new high-throughput novelties regarding sequencing technologies, has been fomenting
an explosion of data, that once scrutinized, aids like never before, in the expansion of our knowledge
pertaining to ecological, metabolic, and physiological processes taking place amidst the “hidden world”
of environmental microbial communities. Indeed, like Delmont et. al. gracefully emphasized [151],
this fairly new field of study has helped us unravel what the “black box” of environmental microbial
communities contains. For example, an incommensurable abundance of novel genes, which can in due
course aid us in our endeavors concerning matters of indisputable importance, like the discovery of new
compounds bearing pharmacological interest, and even towards a better understanding of environmental
processes, such as those relating to agronomical settings, climate change and degradation of pollutants
[151]. Yet, one of the most important contributions that rose with early advents of environmental
gene sequencing is undeniably the ability to better determine the phylogenetic diversity encompassed
within a given environmental sample [152], since it has been long established that more than 99% of
all microbial life found in nature cannot be consistently cultivated through standard procedures [153].
Thus, culture-independent methodologies, including the comparative analysis of small ribosomal RNA
subunits (mainly 16S rRNA), previously established by Olsen, Pace and colleagues in 1986 [154], laid
the foundations for further innovations in light of metagenomic analysis, carving the path for more
recent approaches, that are currently commonplace. Particularly PCR (Polymerase Chain Reaction)
and whole-genome shotgun oriented sequencing techniques, that ultimately bestow researchers with
a collection of predominantly unbiased data, representing the vast majority of genes pertaining to all
microbial representatives of the given sampled communities [155].
Although contrastive with a sole genome, one might, quite presumably, acknowledge a
metagenome as a discrete unit of genetic information, for several reasons. Firstly, one should keep
in mind that bacteria are social organisms, mostly living in well established communities, that together,
might function as a purported biological system, relying on the full set of genes that the microbiome
comprises. Within their naturally occurring communities, bacteria typically form close cooperative loops
resulting in indirect benefit to all species involved [156], being able of complementing each other, in order
to reconstitute complete biochemical pathways and metabolic functions. Thusly, it comes as no surprise
that those metabolic exchanges and symbiotic biochemical interactions are found to be ubiquitous amidst
microbial communities [157,158]. Secondly, HGT promotes interrelationships between bacterial species,
compelling them to cooperate [128], and consequently avoiding the emergence of cheaters (bacteria that
benefit from the cooperation of other bacteria, without contributing themselves) within the microbiota.
Thirdly, by addressing a metagenome, one is granted access to the repertoire of genes involved in
adaptation to the environment, as well as cooperation [159], of the bacterial communities represented
within the sequenced sample, mostly due to the fact that most of these traits are often encoded in mobile
genetic elements [159], and thus can be shared by different, eventually unrelated bacteria. For these
reasons, one can conceive a metagenome as a representative unit of all bacterial communities’ genomes
encompassed within the environmental sample that has been sequenced.
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Still appertaining to the subject at hand, one can also accede to the fact that mining for genes in
metagenomes comes as a trustworthy way to access the selective pressures a given bacterial population
is being subject to, as well as the co-selection, or co-representation, of genetic traits comprised by the
microbiome as a whole. The accomplishment of mining for genes in metagenomes, together with the
unceasing submission of new data, and the consistent increase of public access to the copiousness
of biological information depicted in latter, throughout several databases, annotation and analysis
platforms [160-162], might aid microbial ecologists in their research endeavors, by providing answers
to biological questions, as well as supporting the evaluation and development of new hypotheses
[151]. Notwithstanding the cited databases, the present dissertation, for all its purposes, would like
to especially distinguish the MetaGenomics RAST (Rapid Annotation using Subsystems Technology)
server (MG-RAST) [160], which has underwent an amazing expansion ever since its debut in 2008,
either in the quantity and diversity of metagenomic data and even whole projects upholded within said
database [163], with a great deal of them being publicly available; as in the broad variety of automatically
pre-processed files that undergo a file formating pipeline as to provide the user with sequence quality
assessment and annotation with reference to numerous renown databases, along with a user-friendly
post-annotation platform for further analysis and visualization of metagenomic data [164]. In addition
to all these features, one should also mention that all metagenomic data gathered within this database is
conveniently reachable through its application program interface (API) [165].
Shifting one’s attention to the sum of microorganisms that share our body space, also known as the
human microbiota [7], one might as well be acquainted with the fact that it has become a highly focused
theme of current research concerning microbial ecology [8,166]. Some examples of groundbreaking
research conducted over the past few years on the human microbiota have assuredly been directed
towards the niche that comprehends the highest distribution of bacteria within our body – the human
gut. With special emphasis on a few prominent topics, including but not limited to, host-microbiota
relationships [5]; the ecological and evolutionary features regarding the former milieu [4]; and with
the bacterial diversity subsumed therein, along with its subsequent genetic and metabolic diversity
[8,12,13,167]. As to underline a pertinent example, one can be apprised with a rather illustrious study,
authored by Tanya Yatsunenko and colleagues [167], that delved on the genetic and metabolic diversity
depicted by gut microbiomes amongst human populations having contrastive cultural, sanitary, dietary,
and socio-economic lifestyles [167]. This study probed bacterial diversity through means of 16S rRNA
gene analysis, in fecal samples donated by 531 individuals (aged 0 to 70 years), and also analyzed the
complete set of gut metagenomes from a subset of 110 subjects (aged 0 to 53 years), belonging to a cohort
that enclosed healthy children and adults spanning from two regions of the Venezuelan Amazon, three
provinces of Malawi, and four cosmopolitan areas of the USA [167]. One of several findings provided
by the appliance of the foregoing methodology, showed that the first three years of an individual’s life
presented core features of the gut microbiota’s functional maturation, characteristics that were identified
as being shared by all three populations [167]. And that during this period the bacterial phylogenetic
diversity present in the human gut increases gradually, almost linearly, confirming once again that the
human gut microbiota begins establishing itself right upon birth, undergoing maturation during the first
years of life. Like it had already been reported in, at least, one previous study that also made use of
16S rRNA gene analysis [168]. Furthermore, after this 3-year time span, the diversity of bacterial taxa
seems to reach a succeeding plateau, later stabilizing throughout adulthood [167]. Another interesting
result included unmistakable discrepancies in bacterial communities and functional gene repertoires
between individuals from the USA and those native to the other two countries, being these distinctive
traits evident from early infancy, throughout to adulthood [167]. One might also be further cognizant
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of the fact that the conclusions drawn from this particular study, raise a whole new assortment of very
interesting questions and prepositions. Whereas the research conducted by these authors vehemently
suggests that the human gut microbiota must be reconsidered when evaluating various human features,
such as development, nutritional status, and physiological disparities; additionally concerning itself with
the impact of westernization on the human gut microbiome, and how these changes might potentially
mediate the suite of pathological states [167]; this dissertation independently oughts to ask whether
different levels of access to putative medical care, and therefore pharmaceutical drugs, intrinsic to
different and contrastive human populations, also render different grades of AR determinants and VFs
acquisition, by the gut microbiome of said populations.
The microbial diversity and community dynamics rendered by the human gut microbiota is
constitutional to a vast myriad of physiological and metabolic processes that ultimately contribute to
the endowment of a healthy-state to its host [166]. Researchers have been aware of the connection
between the mammalian immune system and gut microbial communities for many years [166], but
even so, contemporary research continues to unravel the intricacies of said relationship [169]. However,
our general health is prone to a whole spectrum of intertwined and concomitant competencies exerted
by the gut microbiota, that reach far beyond such affair [166,170]. Many diseases, regularly complex
and dysbiotic in nature [21,22], have been continuously correlated with changes to the microbiota and
its microbiome [166], unfolding, along these lines, how intrinsically connected one is with its gut
microbiota, together with the role it plays in health and disease [15-19,166,170]. In addition to the
previous statement, if one further reiterates on the third subsection of this dissertation’s introduction,
one can recollect that opportunistic bacterial pathogens often arise from environmental settings [77],
and that environmental microbiomes pose as abundant reservoirs of AR genes [84,89,105], along with
human gut microbiomes [91], sometimes even overlapping and sharing the same resistance determinants
[90]. Indeed, the presence of AR genes amidst the human gut microbiome, and all the implications
this phenomenon bears, has been extensively studied by several research groups worldwide, with
special reference to the one led by Gautam Dantas [91,105,171-174]. Some of the most recent
findings, collectively gathered by his team, have concluded that environmental factors shared within
families shape resistome development in healthy infants, as early as a few weeks after birth, even
without exposure to antibiotics [171,173]; that the gut microbiome of Amerindian communities, with
no known previous contact with westernization, nor pharmaceutical-grade antibiotics, were shown to
carry AR genes, syntenic with mobile genetic elements [172]; and the presence of core AR genes
in low-income human settings, that cross environmental boundaries, bearing possible associations
with HGT phenomena [174], just to name a few. The latter settings can very well add up to a
co-representation of both resistance and virulence determinants encoded by potentially opportunistic
pathogens dwelling amidst our gastrointestinal tract – for all the aforementioned reasons stated in the
previous subsection –, boldly asserting on the ever-growing evidence that seems to show that AR
determinants are in fact widespread throughout human gut microbiomes, even in healthy newborn
individuals [171,173]. Indeed, metagenomic studies have already shown us that there is, as a matter
of fact, shared presence of pathogenic species of bacteria, such as those currently defying medical
practice, and AR genes, amongst microbial communities dwelling in the environment, especially those
under direct anthropogenic influence, for instance, manured soils [175], and wastewater treatment plants
[176,177]. Nevertheless, to the knowledge of all group members involved in the very project which has
led to the writing of this dissertation, there are no scientific records on the evolutionary dynamics ruling
the epidemiology of resistance and virulent bacterial determinants collectively, in any reported biome,
despite the preexistent awareness the scientific community possesses regarding the success and speed of
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bacterial adaptation, concerning AR together with the emergence of multi-resistant pathogenic bacteria.
Mining for genes, or protein sequences, amongst metagenomic data commonly relates to a
central paradigm of most bioinformatics and computational biology studies – the inference of sequence
similarity through the virtue of computational search algorithms. As William R. Pearson expounded
in an original and enlightening review [178], the step that appertains to sequence similarity search
of homologous sequences is usually one of the first, and most informative milestones in any analysis
referring to the characterization of newly described sequences [178]. Briefly recounting the annals of how
sequence similarity searching algorithms came to be, one should know that it all began with the heuristic
approach devised by Needleman and Wunsch in 1970 [179], which first introduced a calculation method
reliant on a substitution matrix (a matrix that describes the rate at which a character – nucleotide or
amino acid – present in a given sequence, changes to another character over time), allowing the conferral
of a score (i.e.: similarity score) as the end result of the alignment procedure applied to the totality of the
two sequences being compared. This alignment methodology is commonly referred to as the global
alignment algorithm, and it’s still presently used for optimal global sequence alignment, especially
when the end quality of the global alignment precedes all other requirements. Meanwhile, numerous
other heuristic algorithms were suggested, but unfortunately these were either devoid of biological
significance, or uninterpretable [180]. Even so, in 1974 Sellers developed of a true metric measure,
allowing the calculation of the disparity between two given sequences, representing in this fashion the
minimum number of mutations – insertions, deletions or substitutions – required in order to convert
one sequence into another [181]. Yet, a long-lasting success decisively came, with the contrivance of
the local alignment algorithm, by Smith and Waterman in 1981 [180]. The Smith-Waterman algorithm
differs from the one designed by Needleman and Wunsch, almost a decade earlier, in the instance that
instead of comparing the totality of the whole two sequences being aligned, it compares several segments
of all possible lengths from these sequences, thus optimizing their similarity score as an end result.
It should be mentioned that for all current bioinformatics purposes, one does not usually implement
the Smith-Waterman algorithm per se, being acquainted with the fact that nowadays, there are better
alternatives bearing improved scalability [182], and accuracy [183].
There are, at least, two strong catalytic factors that often lead researchers to choose sequence
homology search programs based on local alignments, in deterrence of global alignment ones. Firstly,
one should know that obtaining correct alignments in regions that reveal low similarity between distantly
related biological sequences is a computationally challenging task. Mainly because mutational events
add too much undercurrent information, over the evolutionary timescale that separates both sequences
being compared, to concede a substantially accurate comparison of the depicted regions [184]. As such,
local alignment algorithms avert these regions entirely, rather focusing on those that share evolutionarily
conserved similarity cues [184]. Secondly, there is a statistically sound model for local alignments
[185,186], enabling in such a way, a certain degree of reliability for optimal local alignments, further
allowing the calculation of better scores for the latter. These scores follow an extreme value distribution,
when taking the alignment of unrelated sequences into account. The preceding feature concedes the
creation of an expectation value (E-value) – based on the P-value correction applied to multiple testing
– for the optimal local alignment between the two sequences being compared [185], which comes as
a common statistical estimate of many homology search programs. Simply put, this E-value is an
estimation of how often two unrelated sequences would generate an optimal local alignment, having
by chance, a greater or equal score to the one that is being observed [185], given the total number of
sequences being considered in a multiple testing scenario (e.g.: database size) [187]. Very low E-values
indicate that the two sequences in question might be homologous, therefore they might share a common
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ancestor, and might even, possibly, have similar structures and functions. However, the quality of a
match also depends on other criteria, such as the total length of the alignment produced, and similarity
percentage. For this reason, such statistical measures should also be taken into account when considering
the significance of a match. Even so, and despite the fact that a somewhat ordinary unspoken rule
seems to be that two protein sequences can be reported as homologous if they share more than 30%
identity over their entire length, this criterion might miss many homologies that would be detectable if
one regarded statistical estimates, like E-values, instead [178]. Albeit the fact that alignments sharing
30% identity, and bearing at least 100 or more residues in length, are practically always statistically
significant, many homologies are readily detected with E-values < 1e-10, that are nowhere near a 30%
identity threshold. Hence, E-values should be regarded as much more useful for inferring homology than
identity percentages [178]. Moreover, the implementation of the commonly used 30% identity criteria as
to pinpoint homology between two sequences, harshly underestimates the total number of detectable
homologs by sequence similarity algorithms between very distantly related species (e.g.: yeast and
human), seeing that protein homologs might actually share less than 20% identity [178]. Furthermore,
since E-values are reliant on the total number of multiple comparisons being made – that is to say, the size
of the database –, alignment scores inferred upon searching a bigger database will yield less significance
than the exact same scores inferred upon searching a smaller database instead. Nonetheless, the previous
statement does not imply that the resulting alignments prove homology in one context whereas in the
other they do not. If an alignment is significant – thus providing evidence for homology – in a search
with a database that has a smaller number of entries, the same alignment can also be indicative for
homology in a bigger database, however it might not bear significance, since there are more sequences
being taken into account upon the E-value’s calculation, increasing the number of alignments that could
yield a significant score by chance [178].
As of today, the sheer number of bioinformatics tools and heuristic homology search programs
that, through modifications of the original Smith-Waterman algorithm, provide local sequence similarity
search is tremendous. A few examples might encompass older software like FASTA [188], SSEARCH
[189], and the renown BLAST (Basic Local Alignment Search Tool) [184], along with an expanded
version, that provides DNA-to-protein (BLASTX), protein-to-protein (BLASTP), and even multiple
sequence alignments (PSI-BLAST) [187]. Newer algorithms, and subsequent programs, include BLAT
[190], USEARCH [191], HMMER3 [192], and the latterly DIAMOND [193]. These latest programs,
although depicting a faster performance than BLAST [190-193], or even having a different statistical
reasoning behind its algorithms [192], still lack the statistical reliability and high sensitivity intrinsic to
BLAST, which remains after all these years, as the “golden” standard regarding local alignment tools
[193]. Despite this fact, out of all the illustrated programs above, BLAST still falls short on accuracy
when taking even older, but more precise, programs into account. For instance, SSEARCH implements
the rigorously accurate Smith-Waterman algorithm as modified by Gotoh [182], however its performance
speed is orders of magnitude slower than other programs [189], if not the slowest. Therefore, BLAST can
be relatively seen as the most reliable choice regarding the compromise between speed and sensitivity,
as well as its extensive validation throughout the concerning literature, still being recognized to this date,
as the one possessing the best ratio with respect to the prior variables.
Attending to this dissertation’s objectives, only homology inferred from protein-to-protein
alignments shall be addressed, for the following reasons correspondingly: (i) Since there are only
20 amino acid residues that partake in the synthesis of proteins, but 64 codons in the genetic code,
a certain degree of degeneracy and redundancy arises [194]. Even though some amino acids are
known to be encoded by unique codons (e.g.: methionine and tryptophan), others have as much as
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six codons encoding them (e.g.: arginine, leucine and serine) [194]. This degeneracy portrayed by the
genetic code is the prime factor responsible for the existence of synonymous mutations, also known as
silent mutations (substitution of one nucleotide for another in a protein-coding gene, in such a manner
that the complementary codon encodes for the same amino acid, rendering the resulting amino acid
sequence unmodified) [194]. For the preceding reason, and also bearing in mind (ii) different codon
preferences, depicted by different organisms (i.e.: codon usage bias [195]), when aligning sequences one
might find a much lower level of identity considering nucleotide-to-nucleotide comparisons, than when
taking protein-to-protein sequence comparisons into consideration. (iii) Following William R. Pearson’s
reasoning [178], one can fathom that similarity searches encompassing protein sequences are much
more sensitive than those enclosing DNA, given that nucleotide-to-nucleotide alignments barely discern
homology if the concerning sequences have last shared common ancestry more than 200 ~ 400 million
years ago, whilst protein-to-protein alignments promptly detect homologous sequences that underwent
divergence more than 2.5 billion years ago [178]. (iv) Likewise, alignment statistics pertaining to DNA
comparisons are less accurate than protein-to-protein ones [178]. While protein-to-protein alignments
bearing E-values < 1e-03 can assuredly be used as to ascertain homology, E-values < 1e-06 pertaining
to DNA alignments are recurrently reported to happen by chance [178]. As such, similarity searches
enclosing protein sequences (e.g.: BLASTP) should be favored, for the simple reason of being five to
tenfold more sensitive, and statistically accurate, than similarity searches comprising DNA sequences
[178].
1.6 Objectives
As to conclude, one can acknowledge that the rationale for this dissertation concerns itself with
(i) bioinformatical mining of publicly available metagenomic data stored in a well-established database
[160], as to ascertain the diversity of protein homologues coding for AR determinants and VFs, enclosed
within environmental and human gut metagenomes sampled worldwide [151,167], by making use of
a renown protein sequence homology search algorithm [187], as well as original subsequent filtering
algorithms; (ii) with understanding if these determinants are in fact co-represented in metagenomes (with
the aid of simple linear regressions), and if the co-representation pattern remains the same throughout
three different human populations depicted in the human gut dataset; (iii) with understanding the single
and co-associated pattern portrayed by these determinants throughout the ages of the individuals from
whom the human gut metagenomes were retrieved; and finally, with (iv) statistical analysis of the
magnitude of associations portrayed by both types determinants encompassed therein. Both linear
regressions and statistical approaches shall be accordingly discussed in the methods section.
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2. Methods
2.1 Metagenomic datasets
This project’s human gut query cohort enclosed 110 publicly available metagenomes pertaining to
individuals issuing from different regions of Venezuela (21 metagenomes), Malawi (23 metagenomes),
and the USA (66 metagenomes), as well as comprising a broad age span (0.05 to 53 years), as previously
depicted in the article authored by Yatsunenko et. al. [167]. The environmental query cohort comprised
64 previously selected, and publicly available metagenomes, belonging to 12 different biomes, including
acid mines drainage biofilms; Antarctic aquatic environments; chicken cecum; coral atolls; cow rumen;
deep oceans; human faeces; mouse cecum; oceans; Phosphorous removing sludge; sediments; and soils.
All of which had already been antecedently mentioned in Delmont et. al.’s article [151].
The MG-RAST accession numbers belonging to the 110 human gut metagenomes, were
extracted from the metadata file (“jobs table”) that had been formerly downloaded from the respective
project’s MG-RAST dedicated webpage (http://metagenomics.anl.gov/metagenomics.cgi?
page=MetagenomeProject&project=98). However, the MG-RAST accession numbers referring to
the 64 environmental metagenomes had to be extracted from the article’s appendix, since they are
coming from a collection of selected metagenomes, spanning from different and independent projects.
It should also be mentioned that although Delmont’s team [151] report using a dataset comprised of
77 metagenomes, there are only 70 MG-RAST accession numbers present in the article’s appendix, of
which only 64 are publicly available.
The metagenomes pertaining to the human gut dataset were downloaded on the 3rd of April 2015,
and the metagenomes belonging to the environmental dataset were downloaded on the 17th of November
2015, from the MG-RAST database (http://metagenomics.anl.gov/) [160], under FASTA format,
respectively. The download process made use of successive calls to the MG-RAST API [165], automated
by means of a Z-Shell script that used the respective MG-RAST accession numbers available from
the aforesaid sources as arguments. Each FASTA file comprised protein-coding sequences, retrieved
from the MG-RAST file-formatting pipeline (550.cluster.aa90.faa files), clustered at 90% homology,
containing only non-redundant translated sequences. According to the MG-RAST team [164], these
protein-coding sequences were identified with FragGeneScan [196], and further clustered at 90% identity
with Cd-hit [197]. As such, each FASTA file contains the protein sequences of one representative from
each generated cluster, along with all the singleton sequences that were left unclustered. Thus they
portray the protein diversity enclosed within each metagenome.
2.2 BLASTP, VFDB, Resfams and file processing
For every metagenome present in our query cohorts, a BLASTP [187] search was achieved
against the 2012 version of the Virulence Factor database (VFDB) of bacterial virulence factors protein
families [198], and the Resfams AR Proteins database of bacterial antibiotic resistance protein families
[105]. The BLAST+ executables package (ncbi-blast-2.2.31+ version) was downloaded on the 17th
of November 2015 from the NCBI website (ftp://ftp.ncbi.nlm.nih.gov/blast/executables/
blast+). The VFDB was downloaded on the 11th of November 2013 from its respective website
(http://www.mgc.ac.cn/Vfs/v3index.htm), enclosing a total of 31 functionally-classified FASTA
files of bacterial virulence factor protein sub-families (see Table 2.1), and the Resfams AR Proteins
database was downloaded on the 29th of January 2016, from Dantas Lab’s website (http://www.
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dantaslab.org/resfams), encompassing a total of 123 functionally-classified FASTA files of bacterial
antibiotic resistance protein sub-families (see Table 2.2). A previous approach made use of the Antibiotic
Resistance Genes Database (ARDB) [199], but several hindrances concerning it’s sub-classification by
functional antibiotic resistance protein families made us discard the possibility of using such database.
All FASTA files pertaining to these databases were successively formatted by a Z-Shell script
that made use of the makeblastdb application as to produce BLAST databases from FASTA files, with
the non-default parameter for the creation of BLAST protein databases (-dbtype prot). Every BLASTP
search was automated by way of a Z-Shell script that used both the protein-coding clustered FASTA files
from our query cohorts’ chosen metagenomes, along with the VFDB and Resfams databases’ FASTA
files as arguments. Each BLASTP search was performed with non-default parameters for an E-value
cut-off of 1e-15 (-evalue .000000000000001), and the number 6 tabular output file format (-outfmt
“6”). The total number of BLASTP searches, and subsequent output files, for the chosen query cohort
enclosing human gut metagenomes against both databases was of: 110 (human gut metagenomes) * 31
(VFDB files) + 110 (human gut metagenomes) * 123 (Resfams files) = 16940 outfiles; and for the chosen
query cohort enclosing environmental metagenomes against both databases was of: 64 (environmental
metagenomes) * 31 (VFDB files) + 64 (environmental metagenomes) * 123 (Resfams files) = 9856
outfiles.
Table 2.1: VFDB FASTA files classified by their mechanism and protein family function.
VF mechanism (FASTA file) Protein Family Function
Chaperone/Usher pathway Adhesion & Invasion
Extracellular-nucleation-precipitation pathway Adhesion & Invasion
Type IV pili Adhesion & Invasion
Sortase-assembled pili Adhesion & Invasion
Flagella Adhesion & Invasion
Autotransporters Adhesion & Invasion
Fibronectin-binding proteins Adhesion & Invasion
Fibronogen-binding proteins Adhesion & Invasion
Collagen-binding proteins Adhesion & Invasion
Others Adhesion & Invasion
Type II secretion systems Secretion Systems & effectors
Type III secretion systems & effectors Secretion Systems & effectors
Type IV secretion systems & effectors Secretion Systems & effectors
Type V secretion systems Secretion Systems & effectors
Type VI secretion systems & effectors Secretion Systems & effectors
Type VII secretion systems & effectors Secretion Systems & effectors
alpha-PFT Toxin
beta-PFT Toxin
Superantigens/superantigen-like proteins Toxin
Surface-acting enzymes Toxin
ADP-ribosyltransferase Toxin
Glucosyltransferase Toxin
Guanylate/Adenylate cyclase Toxin
Continued on next page
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Table 2.1 – continued from previous page
VF mechanism (FASTA file) Protein Family Function
Deaminase Toxin
RNA N-glycosidase Toxin
Metalloprotease Toxin
DNase I / genotoxin Toxin
Intracellular PFT Toxin
Siderophore-mediated Iron Uptake Iron Acquisition
Heme-mediated Iron Uptake Iron Acquisition
Transferrin and Lactoferrin-mediated Iron Uptake Iron Acquisition
Table 2.2: Resfams AR Proteins FASTA files classified by their mechanism and protein family function.
AR mechanism (FASTA file) Protein Family Function
ABC Antibiotic Efflux Pump ABC Transporter
macA ABC Transporter
macB ABC Transporter
msbA ABC Transporter
tolC ABC Transporter
AAC3 Acetyltransferase
AAC3-Ia Acetyltransferase
AAC6-Ia Acetyltransferase
AAC6-Ib Acetyltransferase
AAC6-II Acetyltransferase
Chloramphenicol Acetyltransferase CAT Acetyltransferase
TE inactivation Antibiotic Inactivation
TetX Antibiotic Inactivation
BCII Beta-Lactamase
BJP Beta-Lactamase
BlaB Beta-Lactamase
CARB-PSE Beta-Lactamase
CblA Beta-Lactamase
CepA Beta-Lactamase
CfxA Beta-Lactamase
ClassA Beta-Lactamase
ClassB Beta-Lactamase
ClassC-AmpC Beta-Lactamase
ClassD Beta-Lactamase
CMY-LAT-MOX-ACT-MIR-FOX Beta-Lactamase
CTXM Beta-Lactamase
DHA Beta-Lactamase
DIM-GIM-SIM Beta-Lactamase
Exo Beta-Lactamase
GES Beta-Lactamase
Continued on next page
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Table 2.2 – continued from previous page
AR mechanism (FASTA file) Protein Family Function
GOB Beta-Lactamase
IMP Beta-Lactamase
IND Beta-Lactamase
KHM Beta-Lactamase
KPC Beta-Lactamase
L1 Beta-Lactamase
LRA Beta-Lactamase
MoxA Beta-Lactamase
NDM-CcrA Beta-Lactamase
PC1 Beta-Lactamase
Sfh Beta-Lactamase
SHV-LEN Beta-Lactamase
SME Beta-Lactamase
SPM Beta-Lactamase
Subclass B1 Beta-Lactamase
Subclass B2 Beta-Lactamase
Subclass B3 Beta-Lactamase
TEM Beta-Lactamase
VEB-PER Beta-Lactamase
VIM Beta-Lactamase
baeR Gene Modulating Resistance
baeS Gene Modulating Resistance
blaI Gene Modulating Resistance
blaR1 Gene Modulating Resistance
marA Gene Modulating Resistance
mecR1 Gene Modulating Resistance
mprF Gene Modulating Resistance
phoQ Gene Modulating Resistance
ramA Gene Modulating Resistance
robA Gene Modulating Resistance
romA Gene Modulating Resistance
soxR Gene Modulating Resistance
vanR Gene Modulating Resistance
vanS Gene Modulating Resistance
vanA Glycopeptide Resistance
vanB Glycopeptide Resistance
vanC Glycopeptide Resistance
vanD Glycopeptide Resistance
vanH Glycopeptide Resistance
vanT Glycopeptide Resistance
vanW Glycopeptide Resistance
vanX Glycopeptide Resistance
Continued on next page
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Table 2.2 – continued from previous page
AR mechanism (FASTA file) Protein Family Function
vanY Glycopeptide Resistance
vanZ Glycopeptide Resistance
emrB MFS Transporter
MFS Antibiotic Efflux Pump MFS Transporter
norA MFS Transporter
TetA-B MFS Transporter
TetA-G MFS Transporter
TetA MFS Transporter
TetD MFS Transporter
TetE MFS Transporter
TetH-TetJ MFS Transporter
Tetracycline Resistance MFS Efflux Pump MFS Transporter
TetY MFS Transporter
ANT2 Nucleotidyltransferase
ANT3 Nucleotidyltransferase
ANT4 Nucleotidyltransferase
ANT6 Nucleotidyltransferase
ANT9 Nucleotidyltransferase
ANT Nucleotidyltransferase
Macrolide Glycosyltransferase Other
adeR Other Efflux
adeS Other Efflux
Chloramphenicol Efflux Pump Other Efflux
emrE Other Efflux
APH3 double prime Phosphotransferase
APH3 Phosphotransferase
APH3 prime Phosphotransferase
APH6 Phosphotransferase
Chloramphenicol Phosphotransferase CPT Phosphotransferase
Fluoroquinolone Resistant DNA Topoisomerase Quinolone Resistance
Quinolone Resistance Protein Qnr Quinolone Resistance
adeA-adeI RND Antibiotic Efflux
adeB RND Antibiotic Efflux
adeC-adeK-oprM RND Antibiotic Efflux
MexA RND Antibiotic Efflux
MexC RND Antibiotic Efflux
MexE RND Antibiotic Efflux
MexH RND Antibiotic Efflux
MexW-MexI RND Antibiotic Efflux
MexX RND Antibiotic Efflux
RND Antibiotic Efflux Pump RND Antibiotic Efflux
16S Ribosomal RNA Methyltransferase rRNA Methyltransferase
Continued on next page
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Table 2.2 – continued from previous page
AR mechanism (FASTA file) Protein Family Function
ArmA rRNA Methyltransferase
Cfr23 Ribosomal RNA Methyltransferase rRNA Methyltransferase
Erm23S Ribosomal RNA Methyltransferase rRNA Methyltransferase
Erm38 rRNA Methyltransferase
ErmA rRNA Methyltransferase
ErmB rRNA Methyltransferase
ErmC rRNA Methyltransferase
TetM-TetW-TetO-TetS Target Protection
Tetracycline Resistance Ribosomal Protection Protein Target Protection
Next, a filtering algorithm was applied, under the form of an AWK script, as to screen the
output files for alignments that fulfilled the requirements for a minimum of 60% sequence “homology”
(percentage of the query that aligned with the subject more than 60%) over a 75% alignment overlap.
All protein sequences that were unable to fulfil these criteria were accordingly discarded. Furthermore,
for a given protein present in a metagenome used as a query, only the best hit (i.e.: alignment score) for
that specific protein was retrieved from its respective output file, after being validated by the preceding
filtering algorithm. Afterwards, duplicate hits for proteins that seemed to characterize both antibiotic
resistance determinants as well as virulence factors – i.e., proteins which had, at least, aligned with
both a protein sequence present in a Resfams database file, and a protein sequence present in a VFDB
file – were removed, by virtue of an algorithm also implemented through a Z-Shell script. Hits (i.e.:
alignments) that passed all filtering procedures described insofar were considered valid. This way we
have taken into account the proteins of each metagenome that are homologues to either an AR or a VF
determinant.
Two tables (data warehouses) enclosing all valid hit counts from the filtered output files, were
consecutively created, for each metagenomic dataset, also through the usage of yet another Z-Shell
script: one table for the hit counts resultant from the BLASTP search of the foregoing metagenomes
against the Resfams database; and another one for the hit counts resultant from the BLASTP search of
the foregoing metagenomes against the VFDB, respectively. The sums of all VFDB, and Resfams hits,
were further filtered for uniqueness per metagenome, upon the tables’ creation – a given protein sequence
identifier, from its respective metagenome, was not represented more than once, amidst the total number
of representatives. These two tables were then merged into one final table via a Python script, for both
datasets, proceeding differently, when attending to the disparate natures of their respective metagenomes’
metadata: for the human gut metagenomic cohort, both tables were merged along with the metagenomes’
MG-RAST accession numbers, total count of protein sequences present in each metagenome, name-code
of the metagenomes, together with the age, location and country of the individuals from which the
metagenomes were gathered; whereas for the environmental metagenomes, both tables were merged
along with the metagenomes’ MG-RAST accession numbers, total count of protein sequences present
in each metagenome, and the respective biome from which the metagenomes were gathered. The
abovementioned filters and algorithms were implemented making use of UNIX scripting languages
(GNU AWK version 4.0.1, and Z-Shell version 5.0.2), and the Python programming language (version
2.7.6), under a Linux environment. For a concise diagram depicting all the workflow described thus far
please refer to Figure 2.1.
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Figure 2.1: Flowchart of the implemented file-formatting workflow.
37
2.3 Linear Regressions and Statistical Analysis
The major aim of our work was to check whether a metagenome with more ARd than expected,
had more or less VFd than expected – where ARd is the diversity number (hit counts) for homologues
of antibiotic resistance protein families, and VFd is the diversity number for homologues of virulence
factors protein families, respectively. One should expect that the number of ARd (or of VFd)
increases with the metagenome’s total number of protein sequences (its “size”) according to the “law
of diminishing returns”. However, to simplify our analysis, and because there are many proteins in
each functionally-characterized family of AR and VF determinants, we shall assume a linear relationship
between ARd and metagenome size, whilst doing the same for VFd. Our results show that the assumption
of linearity is reasonable. In order to study such relationship, we proceeded as follows. Given the
assumption of linearity, we use the simple linear regression formula:
yi = axi +b (Equation 2.1)
Where, following the least-squares approach, x is a variable believed to hold a linear relationship with
the other variable y; a is the slope of the linear fit; and b is the y-intercept. Further along, and as to
better interpret the linear relationship between ARd and VFd, these hit counts were divided by the slopes
extracted from their linear fit with the total protein sequence count of their respective metagenomes,
and further divided by the total protein sequence counts as well, respectively (see Equation 2.2 and 2.3.
for the corresponding simplified formulae). This way ARd and VFd were plotted on the same scale,
and were also accordingly standardized by the total number of protein sequences contained in their
respective metagenomes. Moreover, we define α as the slope of the regression line of ARd on the size
of the metagenomes, and β as the slope of the regression line of VFd on the size of the metagenomes:
ARd = α.Size (Equation 2.2)
V Fd = β .Size (Equation 2.3)
Thus, a metagenome i of a given size (Size(i)) is expected to have:
ARd(i) = α.Size(i) (Equation 2.4)
antibiotic resistance protein families’ homologues, and:
V Fd(i) = β .Size(i) (Equation 2.5)
virulence factors protein families’ homologues (to clarify the meaning of these equations, we draw Figure
2.2 with hypothetical examples). This is the case of metagenomes “1” and “3” in Figure 2.2. Naturally,
some of the metagenomes do not match these predictions (the case of all metagenomes of Figure 2.2,
with the exception of metagenomes “1” and “3”). As such, we ask what happens when these predictions
are not met (Figure 2.3), being that different contexts can be conceived.
Suppose that a given virulence plasmid is very epidemic and spreads among several species of
a bacterial community. After that, an incoming similar plasmid coding, for example, for antibiotic
resistance, would have a certain degree of difficulty in order to spread and stabilize amidst the foregoing
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community. The reason underlying this occurrence is that, being similar to each other, the two plasmids
are incompatible, meaning that they are not stable in cells – one of them is lost during bacterial division.
For this hypothetical and specific situation, the presence of certain virulence genes implied an absence
of certain antibiotic resistance genes, and consequent gene products, respectively. In other words, this
virulence plasmid would increase VFd but decrease the expected value of ARd for this metagenome, a
trade-off rule: more genes of a certain kind implying less of another, albeit it might be the other way
around.
Figure 2.2: Schematic representation of ARd and VFd counts of six hypothetical metagenomes and their relationship
with the size of each metagenome.
Slopes α and β are those of Equations 2.4 (A) and 2.5 (B), representing the slope of the regression line of ARd on sizes and
of VFd on sizes, respectively. Metagenomes are numbered between “1” and “6”. Metagenomes “1” and “3” fall on the line.
Metagenome “2” has more ARd (diversity number for homologues of antibiotic resistance protein families) and more VFd
(diversity number for homologues of virulence factors protein families) than expected, metagenome “5” has less ARd and less
VFd than expected. Metagenome “4” has less ARd than expected, but more VFd than expected, and metagenome “6” an excess
of ARd but a deficit of VFd (the opposite of metagenome “4”). Should we expect more instances like those of metagenomes
“2” and “5” or like those of metagenomes “4” and “6”? Or all of them equally?
As a second hypothetical situation, one can suppose that a given bacterial genome, encompassed
within a given sequenced human gut metagenome, confers virulence. As to fight this pathogen the
host eventually had to undergo antibiotic treatment, thus selecting for antibiotic resistance genes. These
antibiotic resistance genes may even be encoded by another bacterial genome (belonging to the same
microbiome, and further metagenome). According to this scenario, the presence of a given VF in a
metagenome implies selection of a certain AR gene, hence ultimately portraying co-representation of
VF and AR determinants (and not a trade-off situation akin to the one before). This circumstance leads
to an increase of both ARd and VFd, eventually driving to an excess of both.
Finally, we may also expect a third scenario: that there is no general rule for outsiders. Strictly
speaking, some metagenomes with an excess of ARd may also have an excess of VFd (or deficit of both),
but other metagenomes with an excess (or deficit) of ARd have a deficit (or excess) of VFd.
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2.2.A 2.2.B
Figure 2.3: Relative expected ARd and VFd of outsider metagenomes.
Metagenomes “1” and “3” of Figure 2.2 would appear on coordinates (1,1). According to Figure 2.2, metagenome “2” has
more ARd (diversity number for homologues of antibiotic resistance protein families) and more VFd (diversity number for
homologues of virulence factors protein families) than expected, and metagenome “5” less ARd and VFd than expected.
Metagenome “4” has less ARd than expected but more VFd than expected, whereas metagenome “6” has more ARd and
less VFd than expected. If most metagenomes are like metagenomes “2” or “5”, the regression line amongst metagenomes
has a positive slope (represented here as slope γ). If most metagenomes are like “4” or “6”, we should expect a negative slope
(represented as slope δ ). The possibility of no relationship between the two variables may also occur.
One can now realize that for a given metagenome i, it is expected that:
ARd(i)
α.Size(i)
= 1 (Equation 2.6)
and that:
V Fd(i)
β .Size(i)
= 1 (Equation 2.7)
Being that the expectation under the null hypothesis is that the values of the two sets fall under the (1,1)
coordinates (see Figure 2.3). Should one expect these ratios to be simultaneously lower or higher than
one, or, on the contrary, if one of them is greater than one, the other one should be lower than one?
Perhaps, there might even be different forces ruling this relationship (see Figure 2.3).
As such, the Spearman rank correlation coefficient (Spearman’s ρ , or rs) was used to test the
association between the standardized ARd and VFd. All possible associations between AR and VF
determinants’ hits for protein sub-families were also generated (n = 123 Resfams files * 31 VFDB files =
3813). As to control the expected proportion of rejected null hypotheses, and bearing in mind that this is
a multiple comparison scenario, the Benjamini-Hochberg (BH) post-hoc procedure [200] was applied to
the rs P-values generated this way, ensuring a certain degree of correction over the false-discovery rate,
without giving in to the stringency of a Bonferroni correction (see Figure 2.4).
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Figure 2.4: P-values distribution according to the relative rank of comparison pairs.
“Rank” stands for the ascending order of the sorted rs P-values between the standardized ARd and VFd, gathered from all
possible combinations between AR and VF protein sub-families depicted in the databases. The “number of considered pairs”
designates that, from all possible associations between AR and VF protein sub-families (3813), the rs P-value could only be
calculated for 2716 association pairs, being these the considered ones. As one can see, the rs P-values when corrected by
the Benjamini-Hochberg procedure (“BH”, green line), and plotted against the relative rank of the association pairs, slightly
deviate from the curve portrayed by the original rs P-values (“Unaltered”, black line). Whereas the Bonferroni correction
(“Bonferroni”, red line) appears to be too stringent, abruptly reducing the number of significant rs P-values.
The correlation coefficient (r) and the slope of the linear fits were also calculated as to access the
strength and direction of the linear relationship between the standardized ARd and VFd on the generated
scatterplots. Associations with rs > 0.5, that also had r > 0.5 and a rs P-value < 0.001 were considered
valid upon further visual inspection of the points’ (metagenomes) distribution. Welch Two Sample t-tests
[201] were also performed on the standardized ARd/VFd ratios for each metagenome plotted against the
age of the human host – depicted in the cohort enclosing human gut metagenomes – as to to test if the
given populations have equal means concerning the latter ratios. The former test is but a derivation of
Student’s t-test, being acknowledged as more reliable when the two tested samples have unequal sizes
[202]. All statistical analysis was conducted with the R programming language (version 3.2.2). Plots
were generated using R’s ggplot2, grid, gtable and scales packages.
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3. Results
3.1 Antibiotic resistance (AR) protein families in the metagenomes
As a first step, the present work asked the two following questions: (i) for a given number of cluster
representative sequences of a metagenome (its “size”), how much does the diversity number of antibiotic
resistance protein families’ homologues (that is, the number of ARd) vary?; and (ii) to what extent does
ARd increase when the size of the metagenomes also increases (Equation 2.2)?
In order to answer these questions, we used a dataset of environmental metagenomes issuing from
diverse ecosystems and biomes [151] (see Methods). In this dataset, a broad variation in ARd can be seen
(Figure 3.1.A), even for a given fixed metagenome size. For example, when the size of a metagenome
is about 1.75e+05, the number of ARd can vary between almost zero (chicken cecum and cow rumen)
to about 3000 (acid mines drainage biofilms). However, there is a close to linear relationship between
the number of ARd and the size of metagenomes. Indeed, upon drawing a regression line fitted through
zero, representing the linear relationship between the two variables, one retrieves r > 0.75, rs > 0.64, rs
P-value < 0.001, and slope = α ≈ 0.0048. A regression line for the subset of metagenomes belonging to
the human gut biome has also been drawn.
Another dataset composed solely of human gut metagenomes from 110 healthy individuals with
ages ranging from 0.05 to 53 years of age, spanning from different regions of the world such as: USA,
Malawi, and Venezuelan Amazon [167], was also studied. In this dataset (Figure 3.1.C) the frequency of
ARd is strongly dependent on the metagenomes’ size (r > 0.91, rs > 0.94, rs P-value < 0.001).
3.2 Virulence factor (VF) protein families in the metagenomes
Next, we ought to ask the same questions as those inquired above, but minding virulence factors
homologues instead, that is: (i) for a given metagenome size, how much does the number of VFd vary?;
and (ii) how much does VFd increase when the metagenomes’ size does the same (Equation 2.3)? As to
provide answers for these questions, we made use of the same datasets as before.
The metagenomes pertaining to the environmental dataset reveal a great diversity of VFd densities
(Figure 3.1.B). For example, when the metagenome size is about 3.7e+05, the number of VFd varies
from about 1000 (human faeces) to more than 7000 (ocean). Since virulence may also be associated with
the colonization of different types of biomes, besides the context of infection, one can expect different
types of these determinants in the environmental microbiomes. In fact, when drawing a regression line
fitted through zero one can see r > 0.66, rs > 0.52, and rs P-value < 0.001. However, in metagenomes
pertaining to the human gut dataset, a strong correlation between VFd and the size of the metagenomes
(Figure 3.1.D) can be observed as well (r > 0.63, rs > 0.76, rs P-value < 0.001), albeit with a bigger rs
(human gut dataset: rs = 0.7626, versus environmental dataset: rs = 0.5219), and a much lower rs P-value
(human gut dataset: rs P-value = 2.2e-16, versus environmental dataset: rs P-value = 9.745e-06). In the
human gut dataset and for VFd, the linear associations portrayed by Venezuela and Malawi seem to be
the ones driving the global statistics of r and rs upwards, since the metagenomes belonging to the USA
display a weaker linear association.
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3.1.D
Figure 3.1: Distribution of the diversity number of AR and VF protein families by metagenome.
The vertical axes represent the total diversity count of AR and VF protein families’ homologues (ARd and VFd respectively)
present in the metagenomes. The horizontal axes represent the “size” of the metagenome, that is, the number of cluster
representative sequences - see Methods. A and B each represent the 64 environmental metagenomes. The black line represents
the simple linear regression of best fit for all the environmental metagenomes, where the grey shading is the 95% confidence
interval. The points are scattered showing that the diversity of AR and VF protein families can vary greatly from metagenome
to metagenome. The pink line represents the linear regression of best fit for the human faeces metagenomes subset. In C and
D each dot refers to one of 110 metagenomes pertaining to the human gut dataset. The red (Malawi), green (USA) and blue
(Venezuela) lines depict the linear regressions, respectively, and the black line depicts the regression line for all metagenomes.
In this dataset it is evident that the human gut microbiome shares a less diversified set of AR and VF protein families than the
environmental metagenomes. Data on the simple correlation coefficient (r), Spearman’s rank correlation coefficient (rs) and
the P-value obtained from the latter is shown on all plots. In C and D, statistics pertaining to each individual country are also
shown with the colours attributed to latter, accordingly. αe and βe are the slopes for the environmental metagenomes (in A and
B), whereas αg and βg are the slopes for the human gut metagenomes (C and D).
3.3 The AR / VF correlations
The main purpose of the present work is to evaluate the relationship, if any, between ARd and VFd
(see Figure 2.3). In order to achieve this goal, we excluded from our analysis all the gene products that
were both homologues to AR and VF determinants. Thus avoiding the introduction of a potential bias in
the correlation analysis, issuing from all proteins that could both act as an AR determinant and a VF (see
Methods).
As to address this relationship, we calculated:
ARd(i)
α.Size(i)
(Equation 3.1)
and:
V Fd(i)
β .Size(i)
(Equation 3.2)
for all metagenomes, accordingly depicting the standardized counts for ARd and VFd (see Methods). In
Figure 3.2 one can see that the two variables are positively correlated: an environmental metagenome
with more (less) VFd than expected also has more (less) ARd than expected. Although there is a
large-scale of ARd (r > 0.75, rs > 0.64, rs P-value < 0.001) (Figure 3.1.A) and of VFd (r > 0.66, rs
> 0.52, rs P-value < 0.001) (Figure 3.1.B) in these metagenomes, there is a strong correlation between
ARd and VFd (r > 0.75, rs > 0.82, rs P-value < 0.001)(Figure 3.2). Despite the fact that the values for
ARd and VFd are lower in the metagenomes belonging to the human faeces biome (see Figure 3.1.A and
3.1.B), one can witness a steeper linear fit slope belonging to metagenomes that pertain to the human
faeces biome, relatively to the one portrayed by all environmental metagenomes.
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Figure 3.2: Distribution of AR by VF protein diversity in environmental metagenomes.
Scatter plots with marginal boxplots of Equation 3.1 versus Equation 3.2 of each metagenome, where αe and βe are the slopes
for the environmental metagenomes, calculated in Figures 3.1.A and 3.1.B, respectively. The black line represents the simple
linear regression of best fit, where the grey shading is the 95% confidence interval. The black line in the box plot represents
the median, and the black diamonds represent the mean. The correlations seem to depend on the biome. The pink line
represents the linear regression of the human faeces metagenomes subset, which is steeper than the one depicted by the totality
of environmental metagenomes. There is a significant correlation involving the 12 different environmental biomes (n = 64, r =
0.7547, rs = 0.8256, rs P-value < 0.001, BH post hoc procedure, linear fit slope = 0.6283).
The correlation between ARd and VFd is weaker in the human gut metagenomes dataset (r >
0.55, rs > 0.62, rs P-value < 0.001) (Figure 3.3.A) than in the environmental samples (r > 0.75, rs
> 0.82, rs P-value < 0.001) (Figure 3.2). However, we can distinguish different trends when taking
the geographical location of the human populations under study into consideration. The biggest
contribution to this graph comes from the North American samples, which account for 66/110 (60%)
of the individuals (Figure 3.3.B). In order to better understand the results, we can divide the graph
into quadrants, using the axes set by coordinates (1,1) (see Methods). One can see that there are many
points (metagenomes) located on the first and third quadrant following the regression line. These
points represent the metagenomes for which there is a good correlation between the number of ARd
and VFd; that is, both ARd and VFd are either in excess or in deficit, for a given size. Nevertheless,
some points fall in the second and fourth quadrants. Points that fall in the second quadrant correspond
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to metagenomes for which there are more ARd than expected, but a deficit of VFd. The points that
fall in the fourth quadrant pertain to metagenomes for which an increment in VFd is followed by a
decrease of ARd, not by its increase. When comparing metagenomes collected from Venezuelans
(21/110, or 19% of the metagenomes of the dataset) and Malawians (23/110, or 21%), we can see two
completely different scenarios (Figures 3.3.C and 3.3.D). In the Amerindian gut metagenomes there is
no statistically significant correlation between ARd and VFd (r > 0.32, rs > 0.45, rs P-value = 0.04111).
This result presents itself as quite interesting, when we compare it to the Malawian gut metagenomes
where there is a very strong correlation between ARd and VFd (r > 0.90, rs > 0.87, rs P-value <
0.001). The slope of the regression line depicting the association between ARd and VFd belonging
to Malawian human gut metagenomes (Figure 3.3.D) is about two times steeper than that of the
Amerindian (Figure 3.3.C) and USA metagenomes (Figure 3.3.B). That is, in the Malawian population,
for a given number of VFd, its respective number of ARd is about twofold that of the other two countries.
l
l
l
l
l l
l
l
ll
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
0.6
0.7
0.8
0.9
1.0
1.1
1.2
1.3
1.4
1.5
1.6
1.7
0.5 1.0 1.5 2.0 2.5 3.0 3.5
VFd(i) / (βg.Size(i))
AR
d(i
) / 
(α
g.
Si
ze
(i))
Country l l lMalawi USA Venezuela
l llll ll lll ll l ll lll l l ll l ll l llll l ll l lllll ll ll lll ll lllll ll l l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
r = 0.5572
rs = 0.6289
P = 2.2e−16
slope = 0.2075
48
3.3.A
ll
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
0.6
0.7
0.8
0.9
1.0
1.1
1.2
1.3
1.4
1.5
1.6
1.7
0.5 1.0 1.5 2.0 2.5 3.0 3.5
VFd(i) / (βg.Size(i))
AR
d(i
) / 
(α
g.
Si
ze
(i))
ll l l llll l l ll lll l lll llll ll ll lll ll llll ll ll l l
ll
l
l
l
l
l
l
l
l
ll
l
l
l
lll
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
r = 0.5304
rs = 0.6367
P = 2.081e−08
slope = 0.1897
l
l
l
l
l l
l
l
ll
l
l
l
l
l
l
l
l
l
l
0.6
0.7
0.8
0.9
1.0
1.1
1.2
1.3
1.4
1.5
1.6
1.7
0.5 1.0 1.5 2.0 2.5 3.0 3.5
VFd(i) / (βg.Size(i))
AR
d(i
) / 
(α
g.
Si
ze
(i))
l llll ll lll ll l ll ll
l
l
l
ll
ll
l
l
l
l
l
l
l
l
l
r = 0.326
rs = 0.4519
P = 0.04111
slope = 0.1371
49
3.3.B
3.3.C
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
0.6
0.7
0.8
0.9
1.0
1.1
1.2
1.3
1.4
1.5
1.6
1.7
0.5 1.0 1.5 2.0 2.5 3.0 3.5
VFd(i) / (βg.Size(i))
AR
d(i
) / 
(α
g.
Si
ze
(i))
l l ll l lll ll lll l ll l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
r = 0.9088
rs = 0.8706
P = 2.533e−06
slope = 0.3725
Figure 3.3: Distribution of AR by VF protein diversity in Human gut metagenomes.
Scatter plots with marginal boxplots of Equation 3.1 versus Equation 3.2 of each metagenome where αg and βg are the slopes
calculated in Figures 3.1.C and 3.1.D, respectively. A linear regression line of best fit is represented in each graph, where the
grey shading is the 95% confidence interval. The black line in the box plot represents the median and the black diamonds
represent the mean. Each colored dot represents a metagenome, and the grey lines parallel to the axes represent the (1,1)
reference coordinates. A) Significant correlation involving metagenomes of all sampled human populations – Malawi (red),
USA (green), Venezuela (blue), respectively (n = 110, r = 0.5572, rs = 0.6289, rs P-value < 0.001, BH post hoc procedure,
linear fit slope = 0.2075). B) Significant correlation involving gut metagenomes of USA individuals (n = 66, r = 0.5304, rs =
0.6367, rs P-value < 0.001, BH post hoc procedure, linear fit slope = 0.1897). C) Non-significant correlation involving gut
metagenomes of Venezuelan individuals (n = 21, r = 0.326, rs = 0.4519, rs P-value > 0.001, BH post hoc procedure, linear fit
slope = 0.1371). D) Strong significant correlation involving gut metagenomes of Malawian individuals (n = 23, r = 0.9088, rs
= 0.8706, rs P-value < 0.001, BH post hoc procedure, linear fit slope = 0.3725).
3.4 AR and VF throughout the age of the human gut metagenomes hosts
At this point we wondered whether the associations between AR and VF families, once established
in the human gut microbiome, would remain or not, as a consequence of the genetic organization of the
mobile genetic elements, such as integrons and transposons. For that, we calculated the standardized
ARd/VFd ratios for each metagenome:
ARd(i)
αg.Size(i)
V Fd(i)
βg.Size(i)
=
ARd(i)
αg
V Fd(i)
βg
(Equation 3.3)
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and plotted them against the age of the human host. The gut microbiota is established around the age of
three. From this age forward the microbial diversity seems to be stable [167]. Both the ARd and VFd
counts seem to decrease with the subjects’ age (Figures 3.4.A and 3.4.B). Nevertheless the ARd/VFd
ratios seem to remain rather stable throughout the subjects’ life in the Amerindian and Malawian gut
metagenomes (Figure 3.4.C), despite the decline of individual diversity, both of ARd and VFd with age,
and the small number of Malawian individuals sampled after the three-year-old age mark. Furthermore,
the ARd/VFd ratio means seem to be quite dissimilar when comparing the USA population against
the Malawians (USA ARd/VFd ratio mean = 1.029, Malawi ARd/VFd ratio mean = 0.888, Welch
two-sample t-test P-value < 0.01), and the USA population against the Venezuelan Amerindians (USA
ARd/VFd ratio mean = 1.029, Venezuela ARd/VFd ratio mean = 0.8399, Welch two-sample t-test
P-value < 0.01). Nevertheless, Venezuelans and Malawians possess quite similar ARd/VFd ratio means
(Venezuela ARd/VFd ratio mean = 0.8399, Malawi ARd/VFd ratio mean = 0.888, Welch two-sample
t-test P-value = 0.3682). It comes as important to notice that although Welch two-sample t-test assumes
normality of the population’s distribution, it has been reported to remain quite robust even when these
distributions present themselves as skewed [203], such as the one currently being presented (Figure
3.4.C). Moreover, upon “magnifying” on the first three years of life (Figure 3.4.D), one can see that
the ARd/VFd ratios increase abruptly during the first year of life, and that these ratios reach their peak
during this time period, later stabilizing past the age of three, at least for the Venezuelan and Malawian
gut metagenomes (Figure 3.4.C).
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Figure 3.4: ARd/VFd ratios in human gut metagenomes throughout the age of the individuals.
Distribution of Equation 3.1 (A) and Equation 3.2 (B) of each human gut metagenome (where αg and βg are the slopes
calculated in Figures 3.1.C and 3.1.D, respectively) across the ages (0.05 to 53 years) of 110 individuals from: Malawi (red),
USA (green), Venezuela (blue). C) Distribution of the ARd/VFd ratio (Equation 3.3) across the entire individual’s age span
(0.05 to 53 years); and (D) a zoom to the first three years of life. In Figure C the horizontal lines represent, for each population,
the mean of the ratios. This mean is higher for the US individuals (mean = 1.029), and there are some points that represent
young adults whose gut microbiome accumulates AR genes over VF ones (i.e.: above the y = 1 threshold). The individuals
from the USA bear a quite significant difference upon comparison against the other two populations (Welch two sample t-test
P-value< 0.01, on both comparisons). On the other extreme, Amerindians from Venezuela show the lowest ratios regardless of
age (mean = 0.8399). Malawians show an intermediate mean of 0.888, being similar to that of Amerindians (Welch two sample
t-test P-value = 0.3682).
3.5 The co-representation of AR and VF belonging to the cell envelope
Under the same context of antibiotic exposure, one can conceive that co-selection of AR
determinants and VFs is presumably taking place. We wondered, however, which were the genetic
traits that were more prone to this effect. Thus, after all possible associations between subfamilies of
AR and VF protein pairs had been generated (123 * 31 = 3813) for both environmental and human
gut metagenomic cohorts, a rs cut-off of 0.5 was accordingly applied as to filter the best correlations.
Upon gathering the latter, it was evident that for both datasets, the vast majority falls into the functional
category of multi-drug efflux pumps (AR determinants) associated with either secretion systems, as well
with iron uptake and adhesion mechanisms (VFs), respectively (Table 3.1). Hence, one can ascertain that
amongst the most representative associations between AR and VF traits are those belonging to the cell
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3.4.D
envelope and the general secretion mechanisms.
Table 3.1: Best correlations between AR and VF determinants on the sampled metagenomic datasets.
AR mechanism (FASTA file) VF mechanism (FASTA file) r rs
rs P-value
(BH corrected)
Environmental:
ABC Antibiotic Efflux Pump Heme-mediated Iron Uptake 0.8785 0.8598 2.787245e-14
msbA Heme-mediated Iron Uptake 0.8602 0.8738 2.787245e-14
macB Heme-mediated Iron Uptake 0.8415 0.8889 2.787245e-14
macB Type VI secretion system & effectors 0.8017 0.8367 2.787245e-14
macB Fibronectin-binding proteins 0.7463 0.7549 2.665298e-11
TetM-TetW-TetO-TetS Fibronectin-binding proteins 0.7375 0.7620 1.301533e-11
macB Type III secretion system & effectors 0.7307 0.8205 2.787245e-14
msbA Fibronectin-binding proteins 0.7304 0.7545 2.726477e-11
msbA Others 0.7005 0.7216 5.711802e-10
TetM-TetW-TetO-TetS Others 0.6594 0.7308 2.603417e-10
Human Gut:
MFS Antibiotic Efflux Pump Type VI secretion system & effectors 0.8101 0.6806 6.008628e-14
MFS Antibiotic Efflux Pump Siderophore-mediated Iron Uptake 0.7489 0.7353 4.979333e-14
ABC Antibiotic Efflux Pump Heme-mediated Iron Uptake 0.6477 0.6307 4.979333e-14
ABC Antibiotic Efflux Pump Fibronectin-binding proteins 0.639 0.6603 4.979333e-14
MexW-MexI Type IV Pili 0.6189 0.5899 4.979333e-14
ABC Antibiotic Efflux Pump Others 0.6012 0.5639 1.810177e-09
msbA Fibronectin-binding proteins 0.5538 0.5958 4.979333e-14
54
4. Discussion
In the present dissertation we show that for a given metagenome’s size (total number of
non-redundant sequences), the diversity number for homologues of antibiotic resistance protein families
(ARd), and the diversity number for homologues of virulence factors protein families (VFd) is quite
diverse, when taking the biomes from where the sequenced samples were gathered into comparison. We
also demonstrate that, in most metagenomes pertaining to the chosen cohorts, when the values for ARd
increase, those for VFd also increase.
The variation in diversity of antibiotic resistance (AR) determinants enclosed by environmental
metagenomic samples (Figure 3.1.A) may result from the differential microbial community composition
of the metagenomes, whose genetic diversity can be grouped according to the adaptation to its respective
environment [151]; but also from the fact that selective pressures for the maintenance of antibiotic
resistance genes in environmental microbiomes varies widely from environment to environment
[204-206].
Human gut microbiomes share a less diversified repertoire of resistance, than their environmental
counterparts, as they have already been subjected to adaptation to the environment encompassed by the
gastrointestinal tract. Nonetheless, in human gut metagenomes one can see a very strong correlation
between the diversity of AR protein homologues and the metagenome size (Figure 3.1.C), independently
of the geographical origin of the given human populations. These similar densities of AR genes might
suggest that in human gut microbiomes the diversity of the latter is not influenced by the human lifestyle,
such as: diet, medical care, access to antibiotics or other cultural habits, as it had been previously
described [207], and that the adaptation to the intestinal tract shapes microbial diversity for AR traits as
well. The human gut microbial diversity is established until the age of three, without major interpersonal
variations on the microbial composition upon geographic distribution [167]. Geography and cultural
traditions are, however, responsible for significant differences in the phylogenetic composition of gut
microbiomes pertaining to individuals that originate from different countries, when a broader age-span
is under consideration. Being the most pronounced divergences those that occur between the USA and
the Malawian and Amerindian gut microbiomes [167].
Attending to virulence, one can assert that there appears to be a wide disparity concerning the
diversity and density of virulence factors (VFs) in environmental metagenomes, which might pose as
evidence of the plasticity displayed by environmental bacteria in order to adapt to different environmental
niches (Figure 3.1.B). On the other hand, human gut microbiomes harbour a less diverse VF repertoire,
especially in the samples issuing from the USA (Figure 3.1.D), which seem to indicate an evolution
towards adaptation to the human gut, or lower contact with pathogens, eventually due to vaccination and
sanitation.
One of the most relevant results shown in this dissertation comes from the correlations between
ARd and VFd, whether in environmental metagenomes (Figure 3.2), or in the ones pertaining to the
human gut cohort (Figures 3.3). ARd and VFd present themselves as strongly correlated in environmental
metagenomes, and in one particular subset of the human gut dataset (Figure 3.3.D). The North American
intestinal samples (Figure 3.3.B) show a wide variety of associations between ARd and VFd. There is
a statistically significant correlation between these genetic traits still allowing some variation, being
graphically translated as dispersion. This result in itself reinforces our hypothesis that antibiotic
resistance and virulence are in fact co-associated, as an outcome of previous exposure to antibiotics.
However, there are some interesting exceptions: there are 5/66 (7.5%) dots in the second quadrant of
figure 3.3.B that represent metagenomes where there is an accumulation of ARd by VFd. This outcome
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might suggest that the mobilization of mobile genetic elements as gene cassettes is taking place amidst
these individuals, eventually leading to possible multiresistence phenomena. Analogously, and still
appertaining to the same Figure, there are 3/66 (4.5%) dots that fall directly into the fourth quadrant,
indicating an accumulation of VFd over ARd. The USA population, like other industrialized countries,
is culturally exposed to antibiotics from health care facilities such as hospitals, early discontinuation of
antibiotic therapy, as well as an abuse/misuse of antibiotics in non-clinical settings and processes, such
as agriculture and livestock production [94,95]. Furthermore this country (out of the three sampled ones)
also has the greatest disparity between social classes, which could in due term be translated to different
levels of access to medication and medical treatment.
Among the more similar human gut cohorts – Amerindians from Venezuela and Malawians,
the different effect of antibiotic exposure is quite clear when taking their respective ARd versus VFd
correlations into account (Figures 3.3.C and 3.3.D, respectively). This may also be related to the fact that
the former populations share less divergent human gut microbiomes than the North Americans [167],
which have been reported to possess a distinctive enterotype [208]. Whereas, there is a non-significant
weak correlation between ARd and VFd, amongst the metagenomes spanning from the Venezuelan
individuals, there is a very strong correlation amongst the Malawian ones. This result is quite remarkable,
since it highlights the effect the exposure to antibacterial drugs exerts on the dissemination of antibiotic
resistance, and the co-representation of virulence traits within bacterial communities. Moreover, there
are 18/23 (78%) Malawian metagenomes in Figure 3.3.D, that fall into the first quadrant of the plot,
indicating that the vast majority of the sampled Malawian individuals have more ARd and more VFd
than expected if one considered this increase to be solely reliant on the metagenome’s size. The
collective bacterial microbiome of uncontacted Amerindians has been regarded as a “frozen” relic of
a pre-antibiotic era of the human resistome, despite the fact that it has been known to harbour fully
functional antibiotic resistance genes [172], while the Malawian gut microbiome appears to be much
more exposed, both to antibiotics, and to colonization by pathogens. There is also two times more
ARd per VFd in Malawian human gut metagenomes than in the Amerindian ones. Amerindians have
no known access to pharmaceutical-grade drugs, as they usually make use of traditional indigenous
medicine as to treat diseases, such as infections. Malawi, on the other hand, is one of the poorest
countries in Africa; where the majority of the people live with less than one dollar a day, many people
cope with AIDS, and where many children suffer from severe malnutrition [WHO, s.d.]. Bearing in mind
the fact that nutrition can play a big role on both human gut microbiome and resistome composition
[174,207,209,210], one should also heed that in this country, under UNICEF’s authority, a program
of Ready-to-Use-Therapeutic-Food (RUTF) has been implemented in order to reduce mortality rates
amongst children. However, this RUTF often contains antibiotics such as co-trimoxazole, fact that has
led several authors to question whether the success of this therapeutic food is due to re-nutrition or due to
the addition of antibiotics to the former [211,212], which could very well be affecting the gut’s microbial
composition of the subjects undergoing this kind of treatment. Furthermore, it has also been stated that
there happens to be widespread resistance to almost all antibiotics being empirically used in Malawi due
to the lack of routine microbiologic cultures and sensitivity testing procedures [212], but also due to
self-medication.
The ARd and VFd counts seem to decrease when taking the age of the sampled individuals into
consideration (Figures 3.4.A and 3.4.B, respectively). These results suggest that the mutualistic flora
might become somewhat predominant, and resilient. Nevertheless, the ARd/VFd ratios seem to remain
somewhat stable throughout the life of the individuals pertaining to the human gut metagenomic dataset
(Figure 3.4.C), evidencing a shared increase in diversity of both AR and VF determinants during the first
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year of life (Figure 3.4.D), and then settling in attenuated levels past the age of three in the Venezuelan
and Malawian individuals, whereas the North American subjects display higher ratios between the ages
of 20 and 30. This is an astonishing result because it conveys to some extent that, not only there
is an increased association (co-selection/co-representation) between protein families of VF and AR
determinants in the human microbiome, but also that this correlation seems to persist in the bacterial
community (AR-VF gene pairs endure once settled), as a purported fingerprint of the co-selection
process. Horizontal gene transfer and mobilization could explain these facts through the action of mobile
genetic elements such as transposons and integrons. This ratio is much higher in the USA, indicating an
association above what’s expected (as shown by the lines of the ARd/VFd averages). Despite the fact
that there is less phylogenetic diversity within this group, some metagenomes tend to keep high AR / VF
gene product rates. The selective pressure by the presence of different antibiotics might be stimulating
the mobilization of gene cassettes or transposons (leading to multidrug resistance).
Between all the possible statistical AR and VF gene families’ correlations, the best matches are
amongst those belonging to the bacterial cell envelope (Table 3.1). This result is not surprising, as
many proteins that belong to the secretory system or the secretome (the collective sum of all secreted
proteins from a given species) itself, are frequently encoded on mobile genetic elements [128,213]. The
most relevant cases of resistance mechanisms to antibiotics are components of multidrug efflux pumps
and export machineries; and virulence factors that belong to mechanisms of iron uptake (heme uptake
proteins and siderophores), as well as secretion systems involved in invasion and adherence to host cells.
There are a few bibliographic records of these combinations. For instance, biofilm production is known
to be related with the activity of some VFs, like type IV pili, and at least one reported type IV secretion
system [46,136,147]. Furthermore, biofilm formation in a S. aureus methicillin resistant (MRSA) strain
has been known to be essentially reliant on the activity of fibronectin binding proteins [53]. Multidrug
efflux pumps also have direct implications with the formation and maintenance of such matrices [137],
as well as promoting indirect interplay through quorum sensing modulation, which in due course is
known to control biofilm differentiation and further expression of several VFs [149]. There’s also a
two-component regulatory system involved in biofilm formation, and regulation of resistance and virulent
traits [138]. Additionally, it has also been settled that quinolone resistant S. aureus strains up regulate
the production of fibronectin binding proteins when subjected to sub-lethal dosages of ciprofloxacin
[214], which, even though it might pose as an indirect recount of co-selection, still reminiscences on
the plasticity that can be portrayed by VFs when antibiotic compounds are present. It has also been
acknowledged that physiological levels of some cations present within the host, that in such a manner
end up acting as signalling agents of entrance inside the environmental milieu encompassed by the
latter, promote the up regulation of genes encoding putative efflux transporters, oxidoreductases, and
mechanisms of iron uptake either in A. baumannii [215], as in Burkholderia cenocepacia [216], which
could explain the co-association of iron acquisition systems with those of multidrug efflux pumps. On
the other extreme of the scale, associations between all AR subfamilies and the specific VF subfamilies
that encode for toxins, bore no statistical significance.
Despite the fact that correlation does not always indicate causality, all the results gathered by our
team, as well as the underlying nature of the associations described thus far, has led us into the conclusion
that we are in fact in the presence of a causative relationship between antibiotic resistance and virulence
factors, specially in the metagenomes issuing from the human gut cohort.
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5. Conclusive Remarks
To our knowledge, the present dissertation poses as the first piece of evidence on the
co-representation of AR and VF determinants amongst environmental [151] and human gut [167]
metagenomic datasets. As far as we know, it is also the first bibliographical instance where the diversity
of both types of determinants has been statistically addressed together using metagenomic data.
The methodology employed herein settles on a scalable, and reusable, workflow that made use
of a well-established data-retrieving platform [160]; two publicly available and widely acknowledged
protein databases [105,198]; an open source, freely available, and highly renown similarity search
algorithm [187]; as well as several data-mining and statistical programming languages customarily used
in computational biology research.
Future research venturing into larger metagenomic datasets could probably make use of a faster
similarity search algorithm [193] in order to infer homology, while minimizing computational time and
requiring less computational power, perhaps relying on even more stringent or additional cutoff criteria,
as to benefit from the preceding enhancements without compromising on the reliability and veracity of
the resulting alignments.
During this work we came to some conclusions. Firstly, our results confirm that both AR and
VF determinants are widely disseminated throughout numerous environments, with special emphasis
on the niche encompassed by the human gastrointestinal tract of 110 healthy individuals. Secondly,
they also suggest that even though bacterial communities dwelling in the environment have a greater
variation of ARd and VFd when taking the metagenome’s size into account, the human gut bacterial
communities possess a very strong linear dependency when attending to ARd’s distribution on the
size of the metagenomes, and a strong linear relationship concerning VFd against the metagenome’s
size. Additionally, we report that the standardized counts for ARd and VFd portray a very strong
association in environmental metagenomes, where the metagenomes belonging to the human faeces
biome subset display a steeper linear dependency rate than the one portrayed by the totality of this dataset.
Moreover, the standardized counts for ARd and VFd are also significantly correlated in the human gut
dataset, where the metagenomes pertaining to the individuals spanning from the USA present a wide
array of different associations, whereas the Venezuelan samples seem to have no statistically significant
association. The Malawian metagenomes depict the strongest correlation and linear relationship out
of all three countries, as well as possessing twice as more ARd per VFd than the other two countries
represented in the foregoing dataset. Still appertaining to the same metagenomic cohort, we also disclose
that both stardardized counts for ARd and VFd seem to decrease with the subject’s age, whereas the
ARd/VFd ratios appear relatively stable throughout the life of the individuals pertaining to the three
sampled countries, evidencing a common precipitous increase in diversity during the first year of life,
and then later stabilizing past the age of three, with the exception of a few individuals belonging to the
USA. We also present results, which indicate that from the entirety of possible associations between the
functionally categorized VF and AR protein sub-families, those that relate to the bacterial cell envelope
bore the best statistical correlations.
It should be highlighted that the results presented in this dissertation can only provide evidence
for the co-representation of AR and VF determinants amidst environmental and human gut microbiomes
sampled worldwide. Since the chosen metagenomic cohorts lack a temporal scale, and were not probed
for gene proximity nor inclusion in the same mobile genetic elements, our results cannot attest for the
mobilization of both determinants together, i.e.: co-selection and further co-evolution by means of the
same genetic vectors. However, the co-representative nature of our results reinforces on the notion of
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co-selectivity, as it also lays the path for the establishment of new well-directed experimental inquiries.
Further research is required in order to better understand the nature underlying both ARd and
VFd’s distribution in human gut metagenomes throughout the host’s life, preferably by making use of a
metagenomic cohort enclosing several samples of the same individuals during a concise time scale; and
also as to confirm if the best correlated AR and VF protein sub-families are being disseminated together
in the same mobile genetic elements, thus driving forward co-evolution of both types of determinants.
Our results emphasize on the effects that exposure to antibiotics, emerging either from
antimicrobial therapy as from the environment that surrounds us, and food, can exert on the selection for
pathogenic bacterial traits amidst the human gut. This occurrence may further drive and shape changes
on the gene pool of presumably healthy microbiomes. Such perception comes as very important to
all microbiologists, especially those whose research relates to microbial ecology, but also to the entire
community of medical and health professionals, as well as those working in the food industry, along with
all of us as informed and aware citizens.
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